,MOF Name,Ref Code,Property,Value,Units,Condition,Summary,Reference
0,[Cu3(TP)4(N3)2(DMF)2]·3C6H12<|>1a,QONKUB,space group,P21/n,N/A,Single-crystal X-ray analysis,Single-crystal X-ray analysis reveals that 1a still maintains the original monoclinic space group P21/n (Supporting Information Table S1).,10.1021/ic5008457
1,[Cu3(TP)4(N3)2(DMF)2]·2C5H10<|>1b,QONLAI,space group,P21/n,N/A,Single-crystal X-ray analysis,Single-crystal X-ray analysis shows that 1b and 1c also remain in the monoclinic space group P21/n (Supporting Information Figures S4 and S5).,10.1021/ic5008457
2,[Cu3(TP)4(N3)2(DMF)2]·H2O·C10H18<|>1c,QONLEM,space group,P21/n,N/A,Single-crystal X-ray analysis,Single-crystal X-ray analysis shows that 1b and 1c also remain in the monoclinic space group P21/n (Supporting Information Figures S4 and S5).,10.1021/ic5008457
3,[Cu3(TP)4(N3)2(DMF)2]·C4H8O2<|>1d,QONLIQ,space group,P21/n,N/A,Single-crystal X-ray analysis,Single-crystal X-ray analysis indicates that 1d still reserves the monoclinic space group P21/n (Supporting Information Table S1).,10.1021/ic5008457
4,[Cu3(TP)4(N3)2]·3C4H8O2<|>1e,QOMRUH,space group,P21/n,N/A,N/A,Compound 1e also crystallizes in the monoclinic space group P21/n (Supporting Information Table S1).,10.1021/ic5008457
5,[Cu3(TP)4(N3)2]·2H2O·C5H10O<|>1f,QOMSAO,space group,P21/n,N/A,N/A,Compound 1f was prepared by a method similar to that of 1a except that tetrahydropyrane was used instead of cyclohexane. Compound 1f also crystallizes in the monoclinic space group P21/n.,10.1021/ic5008457
6,[Cu3(TP)4(N3)2(DMF)2]<|>1g,QOMSES,space group,P21/n,N/A,N/A,Compounds 1g and 1a have the identical monoclinic space group P21/n (Supporting Information Table S1).,10.1021/ic5008457
7,[Zn(bdc)(bimx)]·1.5H2O<|>compound 1,DOGZEF,density,1.418,Mg m-3,N/A,Dcalc/Mg m-3 1.418,10.1021/cg701041k
8,[Zn(bdc)(bimx)]·1.5H2O<|>compound 1,DOGZEF,crystal system,triclinic,N/A,N/A,crystal system triclinic,10.1021/cg701041k
9,[Zn(bdc)(bimx)]·1.5H2O<|>compound 1,DOGZEF,cell volume,1287.8(10),Å³,N/A,V/Å3 1287.8(10),10.1021/cg701041k
10,[Zn(bdc)(bimx)]·1.5H2O<|>compound 1,DOGZEF,space group,P1j,N/A,N/A,space group P1j,10.1021/cg701041k
11,[Zn2(bdc)2(bimx)]·(H2bdc)<|>compound 2,DOGZIJ,density,1.474,Mg m-3,N/A,Dcalc/Mg m-3 1.474,10.1021/cg701041k
12,[Zn2(bdc)2(bimx)]·(H2bdc)<|>compound 2,DOGZIJ,crystal system,triclinic,N/A,N/A,crystal system triclinic triclinic space group P1j P1j,10.1021/cg701041k
13,[Zn2(bdc)2(bimx)]·(H2bdc)<|>compound 2,DOGZIJ,cell volume,1036.1,Å3,N/A,V/Å3 1036.1(6),10.1021/cg701041k
14,[Zn2(bdc)2(bimx)]·(H2bdc)<|>compound 2,DOGZIJ,space group,P1j,N/A,N/A,crystal system triclinic triclinic space group P1j P1j,10.1021/cg701041k
15,SBMOF-1<|>SBMOF-1 ethane,OKAYIK,surface area,145,m²/g,Not specified,"SBMOF-1 is a porous metal organic framework, with moderate surface area of 145 m²/g and calculated porosity of 16% (PLATON).",10.1021/acs.chemmater.5b03792
16,SBMOF-1<|>SBMOF-1 ethane,OKAYIK,porosity,16,%,Not specified,"SBMOF-1 is a porous metal organic framework, with moderate surface area of 145 m²/g and calculated porosity of 16% (PLATON).",10.1021/acs.chemmater.5b03792
17,SBMOF-1<|>SBMOF-1 ethylene,OKAYEG,surface area,145,m2/g,Not specified,"SBMOF-1 is a porous metal organic framework, with moderate surface area of 145 m2/g and calculated porosity of 16% (PLATON).",10.1021/acs.chemmater.5b03792
18,SBMOF-1<|>SBMOF-1 ethylene,OKAYEG,porosity,16,%,Not specified,"SBMOF-1 is a porous metal organic framework, with moderate surface area of 145 m2/g and calculated porosity of 16% (PLATON).",10.1021/acs.chemmater.5b03792
19,SBMOF-1<|>SBMOF-1 acetylene,OKAYAC,surface area,145,m2/g,Not specified,"SBMOF-1 is a porous metal organic framework, with moderate surface area of 145 m2/g and calculated porosity of 16% (PLATON).",10.1021/acs.chemmater.5b03792
20,SBMOF-1<|>SBMOF-1 acetylene,OKAYAC,porosity,16,%,Not specified,"SBMOF-1 is a porous metal organic framework, with moderate surface area of 145 m2/g and calculated porosity of 16% (PLATON).",10.1021/acs.chemmater.5b03792
21,SBMOF-2<|>SBMOF-2 ethylene,OKAYUW,surface area,195,m2/g,Not specified,"SBMOF-2 is a novel material that we recently reported, which shows high Xe/Kr selectivity of about 10 at 298 K and the surface area of 195 m2/g, stable in both air and humidity.",10.1021/acs.chemmater.5b03792
22,SBMOF-2<|>SBMOF-2 ethylene,OKAYUW,porosity,25.6,%,Not specified,SBMOF-2 has a permanent porosity of 25.6% (PLATON) and contains two types of crystallographically different channels (type I and II).,10.1021/acs.chemmater.5b03792
23,SBMOF-2<|>SBMOF-2 acetylene,OKAYOQ,surface area,195,m2/g,Not specified,"SBMOF-2 is a novel material that we recently reported, which shows high Xe/Kr selectivity of about 10 at 298 K and the surface area of 195 m2/g, stable in both air and humidity.",10.1021/acs.chemmater.5b03792
24,SBMOF-2<|>SBMOF-2 acetylene,OKAYOQ,porosity,25.6,%,Not specified,SBMOF-2 has a permanent porosity of 25.6% (PLATON) and contains two types of crystallographically different channels (type I and II).,10.1021/acs.chemmater.5b03792
25,[Cu3L3(H2O)2(DMF)]n<|>1,MAQBIS,chemical formula,C57H59Cu3N2O27,N/A,N/A,MOFs 1 2 3 C54H48O25 Empirical formula C57H59Cu3N2O27 Zn4 C59H61NO27Zn4,10.1002/ejic.201601242
26,[Cu3L3(H2O)2(DMF)]n<|>1,MAQBIS,density,0.733,g·cm-3,N/A,ρ/ g·cm-3) 0.733 0.905 1.018,10.1002/ejic.201601242
27,[Cu3L3(H2O)2(DMF)]n<|>1,MAQBIS,crystal system,Monoclinic,N/A,N/A,Crystal system Monoclinic Trigonal Triclinic,10.1002/ejic.201601242
28,[Cu3L3(H2O)2(DMF)]n<|>1,MAQBIS,cell volume,12516.9(4),Å3,N/A,V/Å3 12516.9(4) 14947.82 4819.52,10.1002/ejic.201601242
29,[Cu3L3(H2O)2(DMF)]n<|>1,MAQBIS,space group,P21/n,N/A,N/A,Space group P21/n R-3 P-1,10.1002/ejic.201601242
30,[Cu3L3(H2O)2(DMF)]n<|>1,MAQBIS,thermal stability,up to 300,°C,N/A,high thermal stability (up to 300 °C),10.1002/ejic.201601242
31,[Cu3L3(H2O)2(DMF)]n<|>1,MAQBIS,surface area,412,m2/g,N/A,Langmuir method to be 555 m2/g (412 m2/g BET),10.1002/ejic.201601242
32,[Zn4OL3]n<|>2,MAQBAK,density,0.905,g·cm-3,N/A,ρ/ g·cm-3) 0.905,10.1002/ejic.201601242
33,[Zn4OL3]n<|>2,MAQBAK,crystal system,Trigonal,N/A,N/A,2 crystallizes in the trigonal R-3 space group.,10.1002/ejic.201601242
34,[Zn4OL3]n<|>2,MAQBAK,space group,R-3,N/A,N/A,2 crystallizes in the trigonal R-3 space group.,10.1002/ejic.201601242
35,[Zn4OL3]n<|>2,MAQBAK,thermal stability,Up to 350,°C,N/A,"TGA curve of 2 shows a weight loss of ∼25.0% from room temperature to 350 °C, corresponding to the loss of disordered water molecules and DMF molecules.",10.1002/ejic.201601242
36,[Zn4OL3]n<|>2,MAQBAK,topology,pcu,N/A,N/A,"From topological perspective, the Zn4O core can be viewed as 6-connected nodes which are further connected by ligands, simplified as rods, to construct the final 3D network with pcu topology.",10.1002/ejic.201601242
37,[Zn4OL3(H2O)(DEF)]n<|>3,MAQBEO,crystal system,Triclinic,N/A,Observed at room temperature after immersion in DEF solution for 72 hours.,"The most prominent structural distinction differing from 2 is that one of the Zn atoms in the Zn4O core of 3 is further coordinated by one DEF molecule and one water molecule, adopting octahedral coordination geometry instead (Figure 2).",10.1002/ejic.201601242
38,[Zn4OL3(H2O)(DEF)]n<|>3,MAQBEO,space group,P-1,N/A,Observed at room temperature after immersion in DEF solution for 72 hours.,"The most prominent structural distinction differing from 2 is that one of the Zn atoms in the Zn4O core of 3 is further coordinated by one DEF molecule and one water molecule, adopting octahedral coordination geometry instead (Figure 2).",10.1002/ejic.201601242
39,"[Zn2(ox)3][{CuI(4,4-bipy)}2] - C2H6O2<|>compound 1",BOFGUZ,thermal stability,240,°C,In N2 atmosphere from room temperature to 800 °C.,Thermal gravimetric analysis (TGA) in N2 atmosphere from room temperature to 800 C shows that complex 1 is thermally stable up to 240 C.,10.1016/j.inoche.2008.04.004
40,{Zn(L1)(H2O)(SO4)0.5-(H2O)0.5}n<|>compound 1,KOCWIJ,space group,P212121,N/A,N/A,The compound 1 crystallized in the chiral space group P212121 is a 3-D chiral coordination polymer possessing three types of homo-chiral helices.,10.1016/j.inoche.2007.12.038
41,[Co(HLdc)]$1.5MeOH$dioxane<|>1<|>1a,QEBGAH,crystal system,Monoclinic,N/A,150(2) K,"""Crystal data for 1. C35.50H31CoN3O9.50, M ¼ 710.56, monoclinic, a ¼ 12.565(2), b ¼ 29.618(5), c ¼ 9.858(2) A, b ¼105.695(3), U ¼ 3531.9(11) A3, T ¼ 150(2) K, space group P21/c (no. 14), Z ¼ 4, 20276 reflections measured, 7379 unique (Rint ¼ 0.064) which were used in all calculations.""",10.1039/c2sc20443f
42,[Co(HLdc)]$1.5MeOH$dioxane<|>1<|>1a,QEBGAH,cell volume,3531.9,A3,150(2) K,"""Crystal data for 1. C35.50H31CoN3O9.50, M ¼ 710.56, monoclinic, a ¼ 12.565(2), b ¼ 29.618(5), c ¼ 9.858(2) A, b ¼105.695(3), U ¼ 3531.9(11) A3, T ¼ 150(2) K, space group P21/c (no. 14), Z ¼ 4, 20276 reflections measured, 7379 unique (Rint ¼ 0.064) which were used in all calculations.""",10.1039/c2sc20443f
43,[Co(HLdc)]$1.5MeOH$dioxane<|>1<|>1a,QEBGAH,space group,P21/c,N/A,150(2) K,"""Crystal data for 1. C35.50H31CoN3O9.50, M ¼ 710.56, monoclinic, a ¼ 12.565(2), b ¼ 29.618(5), c ¼ 9.858(2) A, b ¼105.695(3), U ¼ 3531.9(11) A3, T ¼ 150(2) K, space group P21/c (no. 14), Z ¼ 4, 20276 reflections measured, 7379 unique (Rint ¼ 0.064) which were used in all calculations.""",10.1039/c2sc20443f
44,[Co(HLdc)]$1.5MeOH$dioxane<|>1<|>1a,QEBGAH,surface area,773,m2 g-1,N2 uptake data at 77 K,"""The Langmuir and BET surface areas for the first adsorption process, calculated from the N2 adsorption isotherm data, are 936 and 773 m2 g1, respectively.""",10.1039/c2sc20443f
45,[Co(HLdc)]$2DMF$H2O<|>2,QEBGEL,crystal system,Triclinic,N/A,N/A,"Crystal data for 2. C72H66Co2N10O18, M = 1477.21, triclinic, a = 10.090(2), b = 16.362(3), c = 24.453(5) A, a = 106.75(3), b = 92.97(3), g = 103.16(3), U = 3734(2) A3, T = 150(2) K, space group P1 (no. 2), Z = 4, 33315 reflections measured, 16720 unique (Rint = 0.044) which were used in all calculations.",10.1039/c2sc20443f
46,[Co(HLdc)]$2DMF$H2O<|>2,QEBGEL,cell volume,3734,A3,T = 150(2) K,"Crystal data for 2. C72H66Co2N10O18, M = 1477.21, triclinic, a = 10.090(2), b = 16.362(3), c = 24.453(5) A, a = 106.75(3), b = 92.97(3), g = 103.16(3), U = 3734(2) A3, T = 150(2) K, space group P1 (no. 2), Z = 4, 33315 reflections measured, 16720 unique (Rint = 0.044) which were used in all calculations.",10.1039/c2sc20443f
47,[Co(HLdc)]$2DMF$H2O<|>2,QEBGEL,space group,P1,N/A,N/A,"Crystal data for 2. C72H66Co2N10O18, M = 1477.21, triclinic, a = 10.090(2), b = 16.362(3), c = 24.453(5) A, a = 106.75(3), b = 92.97(3), g = 103.16(3), U = 3734(2) A3, T = 150(2) K, space group P1 (no. 2), Z = 4, 33315 reflections measured, 16720 unique (Rint = 0.044) which were used in all calculations.",10.1039/c2sc20443f
48,[Co(HLdc)]$2DMF$H2O<|>2,QEBGEL,molecular weight,1477.21,N/A,N/A,"Crystal data for 2. C72H66Co2N10O18, M = 1477.21, triclinic, a = 10.090(2), b = 16.362(3), c = 24.453(5) A, a = 106.75(3), b = 92.97(3), g = 103.16(3), U = 3734(2) A3, T = 150(2) K, space group P1 (no. 2), Z = 4, 33315 reflections measured, 16720 unique (Rint = 0.044) which were used in all calculations.",10.1039/c2sc20443f
49,[Zn2(btca)2(bpy)(H2O)]n·n(DMA)<|>Complex 2,IPIJEY,chemical formula,C28H25N9O6Zn2,N/A,N/A,empirical formula C28H25N9O6Zn2,10.1039/C5CE00833F
50,[Zn2(btca)2(bpy)(H2O)]n·n(DMA)<|>Complex 2,IPIJEY,crystal system,Orthorhombic,N/A,N/A,"Complex 2 shows a (3,4)-connected 2-nodal fsc topology... crystallizes in an orthorhombic system with space group Pbca.",10.1039/C5CE00833F
51,[Zn2(btca)2(bpy)(H2O)]n·n(DMA)<|>Complex 2,IPIJEY,space group,Pbca,N/A,N/A,"Complex 2 shows a (3,4)-connected 2-nodal fsc topology... crystallizes in an orthorhombic system with space group Pbca.",10.1039/C5CE00833F
52,[Zn2(btca)2(bpy)(H2O)]n·n(DMA)<|>Complex 2,IPIJEY,topology,"3D 2-nodal (3,4) connected fsc framework",N/A,N/A,"Thus, the overall structure of 2 can be described as a 3D 2-nodal (3,4) connected fsc framework with a Schläfli symbol of {63.83}{63} calculated with TOPOS17.",10.1039/C5CE00833F
53,"[Zn(btca)(2,2'-bipy)]n<|>Complex 1",not provided,chemical formula,C17H11N5O2Zn,N/A,N/A,empirical formula C17H11N5O2Zn,10.1039/C5CE00833F
54,"[Zn(btca)(2,2'-bipy)]n<|>Complex 1",not provided,density,1.703,g/cm3,N/A,ρcalc (g/cm3 ) 1.703,10.1039/C5CE00833F
55,"[Zn(btca)(2,2'-bipy)]n<|>Complex 1",not provided,crystal system,orthorhombic,N/A,N/A,"Crystallographic studies revealed that compound 1 exhibits a 2D wave-like layered framework, crystallizes in an orthorhombic system with space group Pbca.",10.1039/C5CE00833F
56,"[Zn(btca)(2,2'-bipy)]n<|>Complex 1",not provided,cell volume,2984.44,Å3,N/A,volume (Å3 ) 2984.44(8),10.1039/C5CE00833F
57,"[Zn(btca)(2,2'-bipy)]n<|>Complex 1",not provided,space group,Pbca,N/A,N/A,"Crystallographic studies revealed that compound 1 exhibits a 2D wave-like layered framework, crystallizes in an orthorhombic system with space group Pbca.",10.1039/C5CE00833F
58,Zn(l-LCl)(Cl)2<|>MOF 1,IBICAZ,space group,P61,N/A,Crystallographic analysis.,"MOF 1 crystallizes in the P61 space group, comprising one Zn(II), one l-LCl ligand, and two lattice water molecules in the asymmetric unit.",10.1021/ja2078637
59,Zn(l-LCl)(Cl)2<|>MOF 1,IBICAZ,thermal stability,270,°C,As-synthesized.,TGA performed on as-synthesized 14 revealed that these compounds have thermal stability up to ∼270 C (Figure S17).,10.1021/ja2078637
60,Zn(l-LCl)(Cl)2<|>MOF 1,IBICAZ,proton conductivity,4.45 x 10^-5,S cm^-1,Measured at 304 K and 98% relative humidity.,"The proton conductivities of 1 and 3 were 4.45 x 10^-5 and 4.42 x 10^-5 S cm^-1, respectively, at 304 K and 98% relative humidity (RH).",10.1021/ja2078637
61,Zn(l-LBr)(Br)2<|>MOF 2,IBICED,thermal stability,270,C,As-synthesized MOF.,TGA performed on as-synthesized 14 revealed that these compounds have thermal stability up to ∼270 C.,10.1021/ja2078637
62,Zn(l-LBr)(Br)2<|>MOF 2,IBICED,proton conductivity,0,S cm1,At 304 K and 98% relative humidity.,"Surprisingly, 2 and 4 show almost zero proton conductivity.",10.1021/ja2078637
63,Zn(d-LCl)(Cl)2<|>MOF 3,IBICIH,space group,P61,N/A,Not specified.,"""MOF 1 crystallizes in the P61 space group, comprising one Zn(II), one l-LCl ligand, and two lattice water molecules in the asymmetric unit.""",10.1021/ja2078637
64,Zn(d-LCl)(Cl)2<|>MOF 3,IBICIH,proton conductivity,4.42 x 10^-5,S cm^-1,Measured at 304 K and 98% relative humidity.,"""The proton conductivities of 1 and 3 were 4.45 x 10^-5 and 4.42 x 10^-5 S cm^-1, respectively, at 304 K and 98% relative humidity (RH).""",10.1021/ja2078637
65,Zn(d-LBr)(Br)2<|>MOF 4,IBICON,space group,Isomorphous to MOF 1,N/A,Structural analysis.,"Single-crystal XRD analysis revealed that MOFs 2, 3, and 4 are isomorphous to MOF 1.",10.1021/ja2078637
66,Zn(d-LBr)(Br)2<|>MOF 4,IBICON,thermal stability,Up to 270,C,As-synthesized MOF.,TGA performed on as-synthesized 14 revealed that these compounds have thermal stability up to ∼270 C.,10.1021/ja2078637
67,Zn(d-LBr)(Br)2<|>MOF 4,IBICON,proton conductivity,Zero,S cm1,Measured at ambient temperature and 98% relative humidity.,"MOFs 1 and 3 show high proton conductivity of 4.45  105 and 4.42  105 S cm1, respectively, while 2 and 4 shows zero proton conductivity.",10.1021/ja2078637
68,[Yb2(BDC)3(DMF)2]·H2O<|>(1),not provided,crystal system,Monoclinic,N/A,N/A,"[Yb2IJBDC)3IJDMF)2]·H2O (1) crystallises from a DMF-rich solvent and we previously reported its synthesis and structure in a preliminary communication.17 The material contains a single crystallographic ytterbium coordinated to seven oxygens: six from singly coordinating 1,4-benzenedicarboxylates and one from an O-coordinated DMF, Fig. 1a.",10.1039/C7CE00481H
69,[Yb2(BDC)3(DMF)2]·H2O<|>(1),not provided,cell volume,3384.96,Å3,At 100 K,Table 1 shows selected crystallographic data for the four materials.,10.1039/C7CE00481H
70,[Yb2(BDC)3(DMF)2]·H2O<|>(1),not provided,space group,C2/c,N/A,N/A,"Yb2IJBDC)3IJDMF)2IJH2O)2 (2) was also prepared from ytterbiumIJIII) chloride hexahydrate (1 mmol) and 1,4benzenedicarboxylic acid (1.5 mmol) but the solvent (5 ml in total) contained at least 50% water in DMF.",10.1039/C7CE00481H
71,[Yb2(BDC)3(DMF)2]·H2O<|>(1),not provided,surface area,305,m2 g−1,After calcination at 300 °C,"Interestingly, Yb2IJBDC)3 shows porosity, Fig. 6b, as evidenced by nitrogen adsorption isotherms, which give a BET surface area of 305 m2 g−1 and 376 m2 g−1 for the samples prepared by calcination of (1) and (2), respectively.",10.1039/C7CE00481H
72,[Yb2(BDC)3(DMF)2]·H2O<|>(1),not provided,topology,sra,N/A,N/A,"(1) is constructed from infinite chains of dicarboxylate-bridged seven-coordinate Yb atoms, cross-linked in two directions by BDC to yield diamond-shaped channels (sra topology) lined by coordinated DMF molecules and occluded water.",10.1039/C7CE00481H
73,Yb2(BDC)3(DMF)2(H2O)2<|>(2),MAPGUI,crystal system,Triclinic,none,not specified,Yb2(BDC)3(DMF)2(H2O)2 (2) crystallises in the triclinic space group P¯1.,10.1039/C7CE00481H
74,Yb2(BDC)3(DMF)2(H2O)2<|>(2),MAPGUI,space group,P¯1,none,not specified,Yb2(BDC)3(DMF)2(H2O)2 (2) crystallises in the triclinic space group P¯1.,10.1039/C7CE00481H
75,Yb2(BDC)3(DMF)2(H2O)2<|>(2),MAPGUI,surface area,376,m2 g−1,after calcination of (2),"Interestingly, Yb2IJBDC)3 shows porosity, Fig. 6b, as evidenced by nitrogen adsorption isotherms, which give a BET surface area of 305 m2 g−1 and 376 m2 g−1 for the samples prepared by calcination of (1) and (2), respectively.",10.1039/C7CE00481H
76,Yb2(BDC)3(DMF)2(H2O)2<|>(2),MAPGUI,topology,peu,none,not specified,"The overall structure of (2) shows a 2-fold interpenetrated peu topology, in which each net can be considered as the a-Po type where the centres of the binuclear lanthanide clusters are the nodes, and no accessible pore space is available.",10.1039/C7CE00481H
77,"{[Co3(p-BDC)2(4,4′-dbpt)• 0.5CH3OH]}n<|>Compound 2",MUHNAG,thermal stability,Beyond 316,°C,None specified,The residual framework decomposed beyond 316 °C in a series of complicated weight losses until 885 °C.,10.1039/C5RA06273J
78,"{[Co3(p-BDC)2(4,4′-dbpt)• 0.5CH3OH]}n<|>Compound 2",MUHNAG,topology,8-connected 3D pillared layered architecture,None,None specified,"For 2, with the employment of H2p-BDC, an 8- connected 3D pillared layered architecture with the short Schläfli symbol of (36.418.53.6) is formed.",10.1039/C5RA06273J
79,{[Zn(btz)]·DMF·0.5H2O}<|>1<|>1a<|>1b,YEZFIU,surface area,1151,m2/g,Ar sorption at 87 K,"The apparent Brunauer−Emmett−Teller (BET) and Langmuir surface areas are estimated to be 1151 and 1222 m2/g, respectively.",10.1021/ja3063138
80,{[Zn(btz)]·DMF·0.5H2O}<|>1<|>1a<|>1b,YEZFIU,porosity,45.6,%,Upon removal of guest molecules,"Upon removal of guest molecules, the structure of 1 has a porosity of ∼45.6%, calculated with PLATON software.",10.1021/ja3063138
81,{[Cd(HBTC)(H2O)]-(p-bix)1/2(H2O)2}n<|>complex 2,TOKDON,density,1.837,Mg/m3,N/A,Dc (Mg m3 ) 1.649 1.837 1.566,10.1016/j.molstruc.2008.06.007
82,{[Cd(HBTC)(H2O)]-(p-bix)1/2(H2O)2}n<|>complex 2,TOKDON,crystal system,Monoclinic,N/A,Room temperature,Crystallographic data for complexes 1–3 1 2 3 Formula C60H56Cd3N12O16 C16H17CdN2O9 C60H60N12O18Zn3 Mr 1538.37 493.72 1433.25 Crystal system Monoclinic Monoclinic Monoclinic Space group P2(1)/c P2(1)/c P2(1)/c,10.1016/j.molstruc.2008.06.007
83,{[Cd(HBTC)(H2O)]-(p-bix)1/2(H2O)2}n<|>complex 2,TOKDON,space group,P2(1)/c,N/A,Room temperature,Crystallographic data for complexes 1–3 1 2 3 Formula C60H56Cd3N12O16 C16H17CdN2O9 C60H60N12O18Zn3 Mr 1538.37 493.72 1433.25 Crystal system Monoclinic Monoclinic Monoclinic Space group P2(1)/c P2(1)/c P2(1)/c,10.1016/j.molstruc.2008.06.007
84,{[Cd(HBTC)(H2O)]-(p-bix)1/2(H2O)2}n<|>complex 2,TOKDON,molecular weight,493.72,g/mol,N/A,Crystallographic data for complexes 1–3 1 2 3 Formula C60H56Cd3N12O16 C16H17CdN2O9 C60H60N12O18Zn3 Mr 1538.37 493.72 1433.25,10.1016/j.molstruc.2008.06.007
85,{[Cd(HBTC)(H2O)]-(p-bix)1/2(H2O)2}n<|>complex 2,TOKDON,thermal stability,11.1,%,Below 131 C,"For 2, the first weight loss of 11.1% below 131 C is assigned to the liberation of three water molecules, which is in agreement with the calculated value (10.7%).",10.1016/j.molstruc.2008.06.007
86,[Cd3(BTC)2(m-bix)3]n4nH2O<|>complex 1,not provided,density,1.649,Mg m3,None,Dc (Mg m3 ) 1.649 1.837 1.566,10.1016/j.molstruc.2008.06.007
87,[Cd3(BTC)2(m-bix)3]n4nH2O<|>complex 1,not provided,crystal system,Monoclinic,None,None,Crystallographic data for complexes 1–3 1 2 3 Formula C60H56Cd3N12O16 C16H17CdN2O9 C60H60N12O18Zn3 Mr 1538.37 493.72 1433.25 Crystal system Monoclinic Monoclinic Monoclinic,10.1016/j.molstruc.2008.06.007
88,[Cd3(BTC)2(m-bix)3]n4nH2O<|>complex 1,not provided,space group,P2(1)/c,None,None,Crystallographic data for complexes 1–3 1 2 3 Formula C60H56Cd3N12O16 C16H17CdN2O9 C60H60N12O18Zn3 Mr 1538.37 493.72 1433.25 Crystal system Monoclinic Monoclinic Monoclinic Space group P2(1)/c P2(1)/c P2(1)/c,10.1016/j.molstruc.2008.06.007
89,[Cd3(BTC)2(m-bix)3]n4nH2O<|>complex 1,not provided,molecular weight,1538.37,None,None,Crystallographic data for complexes 1–3 1 2 3 Formula C60H56Cd3N12O16 C16H17CdN2O9 C60H60N12O18Zn3 Mr 1538.37 493.72 1433.25,10.1016/j.molstruc.2008.06.007
90,[Cd3(BTC)2(m-bix)3]n4nH2O<|>complex 1,not provided,thermal stability,Decomposition begins after loss of water,None,Below 192 C,"For 1, the weight loss of 4.65% below 192 C corresponds to the loss of four lattice water molecules (calcd 4.68%). Then the compound begins to decompose.",10.1016/j.molstruc.2008.06.007
91,[Zn3(BTC)2(p-bix)3(H2O)2]n4nH2O<|>complex 3,not provided,density,1.566,Mg m^-3,N/A,Crystallographic data for complexes 1–3 1 2 3 Formula C60H56Cd3N12O16 C16H17CdN2O9 C60H60N12O18Zn3 Mr 1538.37 493.72 1433.25 Crystal system Monoclinic Monoclinic Monoclinic Space group P2(1)/c P2(1)/c P2(1)/c a (Å) 16.655(3) 10.1561(11) 14.346(5) b (Å) 12.245(2) 12.2843(13) 10.127(3) c (Å) 30.400(6) 14.6867(16) 21.105(7) b () 92.057(2) 102.999(10) 99.672(5) V (Å3 ) 6196(2) 1785.4(3) 3022.6(16) Z 4 4 2 Dc (Mg m3 ) 1.649 1.837 1.566,10.1016/j.molstruc.2008.06.007
92,[Zn3(BTC)2(p-bix)3(H2O)2]n4nH2O<|>complex 3,not provided,crystal system,Monoclinic,N/A,N/A,Crystallographic data for complexes 1–3 1 2 3 Formula C60H56Cd3N12O16 C16H17CdN2O9 C60H60N12O18Zn3 Mr 1538.37 493.72 1433.25 Crystal system Monoclinic Monoclinic Monoclinic,10.1016/j.molstruc.2008.06.007
93,[Zn3(BTC)2(p-bix)3(H2O)2]n4nH2O<|>complex 3,not provided,cell volume,3022.6,Å^3,N/A,Crystallographic data for complexes 1–3 1 2 3 Formula C60H56Cd3N12O16 C16H17CdN2O9 C60H60N12O18Zn3 Mr 1538.37 493.72 1433.25 Crystal system Monoclinic Monoclinic Monoclinic Space group P2(1)/c P2(1)/c P2(1)/c a (Å) 16.655(3) 10.1561(11) 14.346(5) b (Å) 12.245(2) 12.2843(13) 10.127(3) c (Å) 30.400(6) 14.6867(16) 21.105(7) b () 92.057(2) 102.999(10) 99.672(5) V (Å3 ) 6196(2) 1785.4(3) 3022.6(16),10.1016/j.molstruc.2008.06.007
94,[Zn3(BTC)2(p-bix)3(H2O)2]n4nH2O<|>complex 3,not provided,space group,P2(1)/c,N/A,N/A,Crystallographic data for complexes 1–3 1 2 3 Formula C60H56Cd3N12O16 C16H17CdN2O9 C60H60N12O18Zn3 Mr 1538.37 493.72 1433.25 Crystal system Monoclinic Monoclinic Monoclinic Space group P2(1)/c P2(1)/c P2(1)/c,10.1016/j.molstruc.2008.06.007
95,[Cu2(OH)(TZI)(H2O)2]n 3nH2O<|>compound 1,FURSES,density,1.984,g/cm3,Not specified,Dc (g m3 ) 1.984,10.1039/C5RA15937G
96,[Cu2(OH)(TZI)(H2O)2]n 3nH2O<|>compound 1,FURSES,crystal system,Monoclinic,Not applicable,Not specified,Crystal system Monoclinic,10.1039/C5RA15937G
97,[Cu2(OH)(TZI)(H2O)2]n 3nH2O<|>compound 1,FURSES,cell volume,778.99(11),Å3,Not specified,V/A˚3 778.99(11),10.1039/C5RA15937G
98,[Cu2(OH)(TZI)(H2O)2]n 3nH2O<|>compound 1,FURSES,space group,P21/m,Not applicable,Not specified,Space group P21/m,10.1039/C5RA15937G
99,[Co2(OH)(TZI)(H2O)2]n 4nH2O<|>compound 2,FUSGOR,density,1.931,g m-3,None specified,Dc (g m3 ) 1.984 1.931,10.1039/C5RA15937G
100,[Co2(OH)(TZI)(H2O)2]n 4nH2O<|>compound 2,FUSGOR,crystal system,Monoclinic,None,None specified,Crystal system Monoclinic Monoclinic,10.1039/C5RA15937G
101,[Co2(OH)(TZI)(H2O)2]n 4nH2O<|>compound 2,FUSGOR,cell volume,815.5,Å3,None specified,V/A˚3 778.99(11) 815.5(2),10.1039/C5RA15937G
102,[Co2(OH)(TZI)(H2O)2]n 4nH2O<|>compound 2,FUSGOR,space group,P21/m,None,None specified,Space group P21/m P21/m,10.1039/C5RA15937G
103,[Co2(OH)(TZI)(H2O)2]n 4nH2O<|>compound 2,FUSGOR,magnetic susceptibility,6.42,emu K mol-1,per Co2 at room temperature,"The cT value per Co2 at room temperature is about 6.42 emu K mol-1, which is much larger than the spin-only value of 3.75 emu K mol1 for three non-interacting octahedral Co(II) ions (S ¼ 3/2, g ¼ 2.00), owing to the strong orbital contribution.",10.1039/C5RA15937G
104,3∞[Cu(pma)2]·2MeOH<|>1a,not provided,crystal system,Monoclinic,Not applicable,Not specified,Crystallisation of 1a occurs in the monoclinic space group P21/n with two formula units per unit cell.,10.1039/c2dt31361h
105,3∞[Cu(pma)2]·2MeOH<|>1a,not provided,cell volume,972.0,Å³,Not specified,Unit cell volume/Å³ 972.0(3),10.1039/c2dt31361h
106,3∞[Cu(pma)2]·2MeOH<|>1a,not provided,space group,P21/n,Not applicable,Not specified,Crystallisation of 1a occurs in the monoclinic space group P21/n with two formula units per unit cell.,10.1039/c2dt31361h
107,3∞[Cu(pma)2]·2MeOH<|>1a,not provided,surface area,567,m² g⁻¹,Not specified,The theoretical BET surface area is 567 m² g⁻¹.,10.1039/c2dt31361h
108,3∞[Cu(pma)2]·2MeCN<|>1b,ADIQAH,crystal system,Monoclinic,N/A,Not specified,"""1b Crystal system Monoclinic""",10.1039/c2dt31361h
109,3∞[Cu(pma)2]·2MeCN<|>1b,ADIQAH,cell volume,965.25,Å3,Not specified,"""1b Unit cell volume/Å3 965.25(13)""",10.1039/c2dt31361h
110,3∞[Cu(pma)2]·2MeCN<|>1b,ADIQAH,space group,P21/n,N/A,Not specified,"""1b Space group P21/n""",10.1039/c2dt31361h
111,3∞[Co(pma)2]·2MeOH<|>2,ADIQEL,chemical formula,C16H12CoN2O4·2(CH4O),None,None,Compound reference 2 Chemical formula C16H12CoN2O4·2(CH4O),10.1039/c2dt31361h
112,3∞[Co(pma)2]·2MeOH<|>2,ADIQEL,crystal system,Monoclinic,None,None,Compound reference 2 Chemical formula C16H12CoN2O4·2(CH4O) Crystal system Monoclinic,10.1039/c2dt31361h
113,3∞[Co(pma)2]·2MeOH<|>2,ADIQEL,cell volume,953.2,Å3,None,Compound reference 2 Chemical formula C16H12CoN2O4·2(CH4O) Unit cell volume/Å3 953.2(3),10.1039/c2dt31361h
114,3∞[Co(pma)2]·2MeOH<|>2,ADIQEL,space group,P21/n,None,None,Compound reference 2 Chemical formula C16H12CoN2O4·2(CH4O) Space group P21/n,10.1039/c2dt31361h
115,{Zn3(HPIDC)3(DMF)22(H2O)2}n<|>compound 1<|>1a,IQEKUM,chemical formula,C42H47N13O18Zn3,N/A,N/A,Crystal data and structure refinements for two compounds. 1a 2b Empirical formula C42H47N13O18Zn3 C60H66N20O25Zn4,10.1016/j.inoche.2016.06.032
116,{Zn3(HPIDC)3(DMF)22(H2O)2}n<|>compound 1<|>1a,IQEKUM,crystal system,Monoclinic,N/A,N/A,"Crystal data and structure refinements for two compounds. 1a 2b Empirical formula C42H47N13O18Zn3 C60H66N20O25Zn4 Formula weight 1218.12 1728.81 Temperature (K) 100(2) 100(2) Crystal system, space group Monoclinic, C2/c Orthorhombic, Pccn",10.1016/j.inoche.2016.06.032
117,{Zn3(HPIDC)3(DMF)22(H2O)2}n<|>compound 1<|>1a,IQEKUM,cell volume,4921(2),Å³,N/A,"Crystal data and structure refinements for two compounds. 1a 2b Empirical formula C42H47N13O18Zn3 C60H66N20O25Zn4 Formula weight 1218.12 1728.81 Temperature (K) 100(2) 100(2) Crystal system, space group Monoclinic, C2/c Orthorhombic, Pccn Volume (Å3 ) 4921(2) 7921(6)",10.1016/j.inoche.2016.06.032
118,{Zn3(HPIDC)3(DMF)22(H2O)2}n<|>compound 1<|>1a,IQEKUM,space group,C2/c,N/A,N/A,"Crystal data and structure refinements for two compounds. 1a 2b Empirical formula C42H47N13O18Zn3 C60H66N20O25Zn4 Formula weight 1218.12 1728.81 Temperature (K) 100(2) 100(2) Crystal system, space group Monoclinic, C2/c Orthorhombic, Pccn",10.1016/j.inoche.2016.06.032
119,{Zn4(HPIDC)4(DMF)42(FMA)2(H2O)}n<|>compound 2<|>2b,IQEKOG,crystal system,Orthorhombic,N/A,N/A,"Crystal data and structure refinements for two compounds. 1a 2b Empirical formula C42H47N13O18Zn3 C60H66N20O25Zn4 Formula weight 1218.12 1728.81 Temperature (K) 100(2) 100(2) Crystal system, space group Monoclinic, C2/c Orthorhombic, Pccn",10.1016/j.inoche.2016.06.032
120,{Zn4(HPIDC)4(DMF)42(FMA)2(H2O)}n<|>compound 2<|>2b,IQEKOG,cell volume,7921(6),Å³,N/A,Volume (Å3 ) 4921(2) 7921(6),10.1016/j.inoche.2016.06.032
121,{Zn4(HPIDC)4(DMF)42(FMA)2(H2O)}n<|>compound 2<|>2b,IQEKOG,space group,Pccn,N/A,N/A,"Crystal data and structure refinements for two compounds. 1a 2b Empirical formula C42H47N13O18Zn3 C60H66N20O25Zn4 Formula weight 1218.12 1728.81 Temperature (K) 100(2) 100(2) Crystal system, space group Monoclinic, C2/c Orthorhombic, Pccn",10.1016/j.inoche.2016.06.032
122,[Co5(μ3-OH)2(5-NH2-bdc)4(H2O)2]·7.5H2O<|>compound 1,OGUPIQ,crystal system,Monoclinic,N/A,Not specified,cryst syst monoclinic,10.1021/cg9005696
123,[Co5(μ3-OH)2(5-NH2-bdc)4(H2O)2]·7.5H2O<|>compound 1,OGUPIQ,cell volume,8478.9,A˚3,Not specified,V (A˚ 3 ) 8478.9(9),10.1021/cg9005696
124,[Co5(μ3-OH)2(5-NH2-bdc)4(H2O)2]·7.5H2O<|>compound 1,OGUPIQ,space group,C2/c,N/A,Not specified,space group C2/c,10.1021/cg9005696
125,[Co5(μ3-OH)2(5-NH2-bdc)4(bpy)0.5(H2O)]·3H2O<|>compound 2,OGUPOW,chemical formula,C37H28Co5N5O22,none,none,"Element analyses for 2: C37H28-Co5N5O22 (1189.29): Calcd (%): C, 37.37; H, 2.37; N, 5.89. Found (%): C, 37.26; H, 2.68; N, 5.78.",10.1021/cg9005696
126,[Co5(μ3-OH)2(5-NH2-bdc)4(bpy)0.5(H2O)]·3H2O<|>compound 2,OGUPOW,crystal system,Monoclinic,none,none,Table 1. Crystal Data and Structure Refinement for 1-2 1 2 empirical formula C32H26Co5N4O27.5 C37H28Co5N5O22 fw 1201.22 1189.29 cryst syst monoclinic monoclinic space group C2/c C2/c T (K) 173(2) 173(2).,10.1021/cg9005696
127,[Co5(μ3-OH)2(5-NH2-bdc)4(bpy)0.5(H2O)]·3H2O<|>compound 2,OGUPOW,cell volume,8793.0,Å³,none,Table 1. Crystal Data and Structure Refinement for 1-2 1 2 empirical formula C32H26Co5N4O27.5 C37H28Co5N5O22 fw 1201.22 1189.29 cryst syst monoclinic monoclinic space group C2/c C2/c T (K) 173(2) 173(2) a (A˚ ) 35.432(2) 35.715(2) b (A˚ ) 11.1832(7) 11.1336(7) c (A˚ ) 21.475(1) 22.146(2) β (deg) 94.836(1) 93.091(2) V (A˚ 3 ) 8478.9(9) 8793.0(1).,10.1021/cg9005696
128,[Co5(μ3-OH)2(5-NH2-bdc)4(bpy)0.5(H2O)]·3H2O<|>compound 2,OGUPOW,space group,C2/c,none,none,Table 1. Crystal Data and Structure Refinement for 1-2 1 2 empirical formula C32H26Co5N4O27.5 C37H28Co5N5O22 fw 1201.22 1189.29 cryst syst monoclinic monoclinic space group C2/c C2/c T (K) 173(2) 173(2).,10.1021/cg9005696
129,[Co5(μ3-OH)2(5-NH2-bdc)4(bpy)0.5(H2O)]·3H2O<|>compound 2,OGUPOW,thermal stability,270,°C,Heated up to 900 °C in N2 at a heating rate of 10 °C min-1.,"The residue is stable up to 270 C, where after pyrolysis of bpy and 5-NH2-bdc occurs and ends at 585 C (weight loss: 68.9%; calc. 69.3%).",10.1021/cg9005696
130,[Co5(μ3-OH)2(5-NH2-bdc)4(bpy)0.5(H2O)]·3H2O<|>compound 2,OGUPOW,magnetic susceptibility,13.44,cm³Kmol⁻¹,Room temperature,"The dc magnetization data under 1 kOe reveal a room temperature χmT value of 13.44 cm3Kmol-1 (corresponding to per Co5 unit), which decreases monotonically upon cooling to a minimum of 1.75 cm3mol-1 at 2 K.",10.1021/cg9005696
131,{[Zn2(L1)(bpe)2]4H2O}<|>compound 8,REYBEE,chemical formula,C48H46N4O14Zn2,N/A,N/A,"Synthesis of {[Zn2(L1)(bpe)2]4H2O}n (8). The same synthetic procedure reported for 7 was used to prepare 8, except that 4,49-bipy was replaced by bpe (0.018 g, 0.10 mmol) to produce colorless block crystals of 8, which were collected in 68% yield (0.035 g, based on H4L1). Anal. Calcd for C48H46N4O14Zn2: C, 55.77; H, 4.49; N, 5.42%. Found: C, 55.61; H, 4.12; N, 5.74%.",10.1039/c3ce26864k
132,{[Zn2(L1)(bpmp)2]6H2O}<|>compound 10,REYCOP,crystal system,Monoclinic,none,none specified,Crystal system Triclinic Triclinic Monoclinic Triclinic Triclinic Triclinic Triclinic Monoclinic Monoclinic Monoclinic Monoclinic,10.1039/c3ce26864k
133,{[Zn2(L1)(bpmp)2]6H2O}<|>compound 10,REYCOP,space group,P2(1)/n,none,none specified,Space group P 1 P ¯ 1 P ¯ 1 C2/c P ¯ 1 P ¯ 1 P ¯ 1 P2(1)/n P2(1)/n P2(1)/n P2(1)/c ¯ 1 P ¯,10.1039/c3ce26864k
134,"{[Zn7(trz)6(1,3-bdc)4(H2O)2]·2H2O}n<|>compound 1",XOVVEK,density,1.665,mg/m3,Room temperature,calculated density (mg/m3) 1.665,10.1021/cg701164u
135,"{[Zn7(trz)6(1,3-bdc)4(H2O)2]·2H2O}n<|>compound 1",XOVVEK,crystal system,Triclinic,N/A,Room temperature,crystal system triclinic,10.1021/cg701164u
136,"{[Zn7(trz)6(1,3-bdc)4(H2O)2]·2H2O}n<|>compound 1",XOVVEK,cell volume,1582.3,Å3,Room temperature,volume (Å3) 1582.3(10),10.1021/cg701164u
137,"{[Zn7(trz)6(1,3-bdc)4(H2O)2]·2H2O}n<|>compound 1",XOVVEK,space group,P1j,N/A,Room temperature,space group P1j,10.1021/cg701164u
138,"{[Zn7(trz)6(1,3-bdc)4(H2O)2]·2H2O}n<|>compound 1",XOVVEK,porosity,28.83,%,N/A,"The total solvent accessible volume of the channel in 1 is estimated to be 456.14 Å3 (28.83%), which shows that 1 is moderately porous.",10.1021/cg701164u
139,{[Zn7(trz)6(hip)4(H2O)2]·8H2O}n<|>compound 2,XOVVIO,density,1.818,Mg/m3,Not specified,The density of 2 (1.818 Mg/m3) is also larger than that of 1 (1.665 Mg/m3).,10.1021/cg701164u
140,[Zn4(trz)4(Hnip)2(nip)]n<|>compound 3,XOVVOU,porosity,21.72,%,N/A,"Compound 3 displays the porosity with 21.72% free area, which can be filled by potential solvents.",10.1021/cg701164u
141,[Zn4(trz)4(Hnip)2(nip)]n<|>compound 3,XOVVOU,topology,"(4, 82)",N/A,N/A,"Two pairs of symmetry-related zinc atoms are linked by two triply bridging trz ligands to generate the basic structural building unit [Zn2(trz)2]2+, and the adjacent [Zn2(trz)2]2+ clusters are then linked by trz molecules to form a 2D {[Zn4(trz)4]4+}n layers (Figure 2a) with (4, 82) topology in the bc plane.",10.1021/cg701164u
142,[Zn5(trz)2(Hbtc)4(H2O)4]n<|>compound 4,not provided,density,2.088,mg/m3,Room temperature,calculated density (mg/m3 ) 1.665 1.818 1.679 2.088,10.1021/cg701164u
143,[Zn5(trz)2(Hbtc)4(H2O)4]n<|>compound 4,not provided,crystal system,Monoclinic,N/A,Room temperature,"Compound 4 is also in a 3D structure containing 2D layer motifs, which are further linked by btc ligands to complete the structure.",10.1021/cg701164u
144,[Zn5(trz)2(Hbtc)4(H2O)4]n<|>compound 4,not provided,cell volume,2162.1,Å3,Room temperature,volume (Å3 ) 1582.3(10) 1594.8(5) 4600.2(8) 2162.1(14),10.1021/cg701164u
145,[Zn5(trz)2(Hbtc)4(H2O)4]n<|>compound 4,not provided,space group,P2(1)/c,N/A,Room temperature,space group P2(1)/c,10.1021/cg701164u
146,[La(PODC)1.5(H2O)]<|>complex 1,XAFXOT,crystal system,Triclinic,N/A,N/A,Complex 1 crystallizes in space group P-1 of triclinic system.,10.1039/c001537g
147,[La(PODC)1.5(H2O)]<|>complex 1,XAFXOT,space group,P-1,N/A,N/A,Complex 1 crystallizes in space group P-1 of triclinic system.,10.1039/c001537g
148,[La(PODC)1.5(H2O)]<|>complex 1,XAFXOT,thermal stability,Stable up to 400,°C,"N2 atmosphere, heating rate of 10 °C min^-1","Between 300 and 400 C, 1 shows no weight loss, which is an indication of its stability up to 400 C.",10.1039/c001537g
149,[Pr(PODC)1.5(H2O)]<|>complex 2,XAFXUZ,thermal stability,Stable up to 300,C,"N2 atmosphere, heating rate of 10 C min1","Similarly, the TGA curve of 2–5 display the first weight loss of 7.7% (calcd 7.0% for 2)... All the frameworks of 2–5 are stable up to 300 C.",10.1039/c001537g
150,[Sm(PODC)1.5(H2O)]<|>complex 3,XAFYAG,thermal stability,Stable up to 300,C,"N2 atmosphere, heating rate of 10 C min1","Similarly, the TGA curve of 2–5 display the first weight loss of 7.7% (calcd 7.0% for 2), 12.2% (calcd. 12.3% for 3), 9.6% (calcd. 9.7% for 4) and 9.7% (calcd 9.6% for 5), respectively, for the loss of the guest water molecules and aqua ligands. All the frameworks of 2–5 are stable up to 300 C.",10.1039/c001537g
151,[Ho(PODC)1.5(H2O)]<|>complex 4,XAFYEK,thermal stability,Stable up to 300,°C,"N2 atmosphere, heating rate of 10 °C min-1",All the frameworks of 2–5 are stable up to 300 C.,10.1039/c001537g
152,[Er(PODC)1.5(H2O)]<|>complex 5,not provided,density,2.185,g cm3,N/A,Complex 5 Dc/g cm3 2.185,10.1039/c001537g
153,[Er(PODC)1.5(H2O)]<|>complex 5,not provided,crystal system,Triclinic,N/A,N/A,Complex 5 Formula C12H18O12N3Er Crystal system Triclinic,10.1039/c001537g
154,[Er(PODC)1.5(H2O)]<|>complex 5,not provided,cell volume,856.4,A3,N/A,Complex 5 V/A3 856.4(3),10.1039/c001537g
155,[Er(PODC)1.5(H2O)]<|>complex 5,not provided,space group,P1,N/A,N/A,Complex 5 Space group P1,10.1039/c001537g
156,[Er(PODC)1.5(H2O)]<|>complex 5,not provided,thermal stability,Stable up to 300,C,"N2 atmosphere, heating rate of 10 C min1",All the frameworks of 2–5 are stable up to 300 C.,10.1039/c001537g
157,[CuL(bpmb)0.5]·DMF<|>compound 2,AVEHAM,density,1.371,g·cm^-3,N/A,Dc / (g·cm^-3) 1.371,10.7503/cjcu20150259
158,[CuL(bpmb)0.5]·DMF<|>compound 2,AVEHAM,crystal system,Monoclinic,N/A,N/A,Compound 2 crystallizes in the monoclinic space group P21/c and gives a 3D framework with {4 4·6 10·8} topology structure.,10.7503/cjcu20150259
159,[CuL(bpmb)0.5]·DMF<|>compound 2,AVEHAM,space group,P21/c,N/A,N/A,Compound 2 crystallizes in the monoclinic space group P21/c and gives a 3D framework with {4 4·6 10·8} topology structure.,10.7503/cjcu20150259
160,[CuL(bpmb)0.5]·DMF<|>compound 2,AVEHAM,thermal stability,Stable up to 300,°C,N/A,"配合物2 的 TG曲线在 50 ~ 300 益范围内出现平台, 对应配位聚合物原组分, 表明该配位聚合物在 300 益 前相当稳定;",10.7503/cjcu20150259
161,[CuL(bpmb)0.5]·DMF<|>compound 2,AVEHAM,thermal stability,300 to 330,°C,N/A,"在 300 ~ 330 益 范围内出现 1 个迅速连续的失重曲线, 失重率 42郾 27% ; 第二阶段(330 ~ 410 益 )配体开始分解, 伴随着化合物骨架的塌陷, 对应化 合物全部分解为 CuO, 最终形成的残留物以 CuO 计量(实验失重值 12郾 19% , 理论失重值 13郾 67% ).",10.7503/cjcu20150259
162,[EuCu(tda)(ina)2(H2O)]·3H2O<|>compound 1,DIBXIX,chemical formula,C16H16CuEuN5O12,N/A,N/A,Empirical formulaa C16H16CuEuN5O12,10.1039/c3ce40346g
163,[EuCu(tda)(ina)2(H2O)]·3H2O<|>compound 1,DIBXIX,density,2.016,g cm⁻³,N/A,Dc/g cm23 2.016,10.1039/c3ce40346g
164,[EuCu(tda)(ina)2(H2O)]·3H2O<|>compound 1,DIBXIX,crystal system,Triclinic,N/A,N/A,Crystal system Triclinic,10.1039/c3ce40346g
165,[EuCu(tda)(ina)2(H2O)]·3H2O<|>compound 1,DIBXIX,cell volume,1129.9(3),Å³,N/A,V/Å3 1129.9(3),10.1039/c3ce40346g
166,[EuCu(tda)(ina)2(H2O)]·3H2O<|>compound 1,DIBXIX,space group,P¯1,N/A,N/A,Space group P¯1,10.1039/c3ce40346g
167,[EuCu(tda)(ina)2(H2O)]·3H2O<|>compound 1,DIBXIX,thermal stability,300,°C,Under a dry air atmosphere,"It can be seen from the TG curve of 1 that there is a plateau in the temperature range of 90–300 uC, hinting that the skeleton of 1 is thermally stable up to 300 uC.",10.1039/c3ce40346g
168,[TbCu(tda)(ina)2(H2O)]·3H2O<|>compound 2,DIBWUI,chemical formula,C16H16CuTbN5O12,none,none,Compound 2 Empirical formulaa C16H16CuTbN5O12,10.1039/c3ce40346g
169,[TbCu(tda)(ina)2(H2O)]·3H2O<|>compound 2,DIBWUI,density,2.052,g cm-3,none,Compound 2 Dc/g cm23 2.052,10.1039/c3ce40346g
170,[TbCu(tda)(ina)2(H2O)]·3H2O<|>compound 2,DIBWUI,crystal system,Triclinic,none,none,Compound 2 Crystal system Triclinic,10.1039/c3ce40346g
171,[TbCu(tda)(ina)2(H2O)]·3H2O<|>compound 2,DIBWUI,cell volume,1121.3,Å3,none,Compound 2 V/Å3 1121.3(3),10.1039/c3ce40346g
172,[TbCu(tda)(ina)2(H2O)]·3H2O<|>compound 2,DIBWUI,space group,P¯1,none,none,Compound 2 Space group P¯1,10.1039/c3ce40346g
173,[TbCu(tda)(ina)2(H2O)]·3H2O<|>compound 2,DIBWUI,magnetic susceptibility,"C=12.22, theta=-4.43","cm3 K mol-1, K",1/xM data,"Compounds 2, 4 and 5 have similar magnetic properties (Fig. 4b, d and e), and the Curie–Weiss fitting result based on the 1/xM data is C = 12.22 cm3 K mol21, h = 24.43 K.",10.1039/c3ce40346g
174,[GdCu(tda)(ina)2(H2O)]·3H2O<|>compound 3,DIBXET,chemical formula,C16H16CuGdN5O12,N/A,N/A,Compound 3 Empirical formulaa C16H16CuGdN5O12,10.1039/c3ce40346g
175,[GdCu(tda)(ina)2(H2O)]·3H2O<|>compound 3,DIBXET,density,2.035,g cm⁻³,N/A,Compound 3 Dc/g cm23 2.035,10.1039/c3ce40346g
176,[GdCu(tda)(ina)2(H2O)]·3H2O<|>compound 3,DIBXET,crystal system,Triclinic,N/A,N/A,Compound 3 Crystal system Triclinic,10.1039/c3ce40346g
177,[GdCu(tda)(ina)2(H2O)]·3H2O<|>compound 3,DIBXET,cell volume,1127.9,Å³,N/A,Compound 3 V/Å3 1127.9(7),10.1039/c3ce40346g
178,[GdCu(tda)(ina)2(H2O)]·3H2O<|>compound 3,DIBXET,space group,P¯1,N/A,N/A,Compound 3 Space group P¯1,10.1039/c3ce40346g
179,[GdCu(tda)(ina)2(H2O)]·3H2O<|>compound 3,DIBXET,magnetic susceptibility,Lowest xMT value around 20 K,cm³ K mol⁻¹,2 K–300 K under a field of 1000 Oe,"However, the magnetic property of compound 3 is different from the above; it has the lowest xMT value around 20 K, which may be due to the increase of the correlation length with the SGd = 7/2 spins aligned along the field direction and the SCu = 1/2 spins aligned along the opposite direction.",10.1039/c3ce40346g
180,[DyCu(tda)(ina)2(H2O)]·3H2O<|>compound 4,DIBXOD,chemical formula,C16H16CuDyN5O12,N/A,N/A,Compound 4 Empirical formulaa C16H16CuDyN5O12,10.1039/c3ce40346g
181,[DyCu(tda)(ina)2(H2O)]·3H2O<|>compound 4,DIBXOD,density,2.059,g cm⁻³,N/A,Compound 4 Dc/g cm23 2.059,10.1039/c3ce40346g
182,[DyCu(tda)(ina)2(H2O)]·3H2O<|>compound 4,DIBXOD,crystal system,Triclinic,N/A,N/A,Compound 4 Crystal system Triclinic,10.1039/c3ce40346g
183,[DyCu(tda)(ina)2(H2O)]·3H2O<|>compound 4,DIBXOD,cell volume,1123.2,Å³,N/A,Compound 4 V/Å3 1123.2(3),10.1039/c3ce40346g
184,[DyCu(tda)(ina)2(H2O)]·3H2O<|>compound 4,DIBXOD,space group,P¯1,N/A,N/A,Compound 4 Space group P¯1,10.1039/c3ce40346g
185,[DyCu(tda)(ina)2(H2O)]·3H2O<|>compound 4,DIBXOD,magnetic susceptibility,"C = 14.81, θ = 26.13","cm³ K mol⁻¹, K","2 K–300 K, 1000 Oe","Compounds 2, 4 and 5 have similar magnetic properties (Fig. 4b, d and e), and the Curie–Weiss fitting result based on the 1/xM data is C = 14.81 cm3 K mol21, h = 26.13 K;",10.1039/c3ce40346g
186,[HoCu(tda)(ina)2(H2O)]·3H2O<|>compound 5,DIBXAP,chemical formula,C16H16CuHoN5O12,None,Not specified,Empirical formulaa C16H16CuHoN5O12,10.1039/c3ce40346g
187,[HoCu(tda)(ina)2(H2O)]·3H2O<|>compound 5,DIBXAP,crystal system,Triclinic,None,Room temperature,Single crystal X-ray diffraction studies revealed that compounds 1–5 are isostructural and crystallize in the same triclinic space group P¯1.,10.1039/c3ce40346g
188,[HoCu(tda)(ina)2(H2O)]·3H2O<|>compound 5,DIBXAP,space group,P¯1,None,Room temperature,Single crystal X-ray diffraction studies revealed that compounds 1–5 are isostructural and crystallize in the same triclinic space group P¯1.,10.1039/c3ce40346g
189,[HoCu(tda)(ina)2(H2O)]·3H2O<|>compound 5,DIBXAP,thermal stability,Stable up to 300,°C,Heating rate of 10 °C min⁻¹ under a dry air atmosphere,"It can be seen from the TG curve of 1 that there is a plateau in the temperature range of 90–300 °C, hinting that the skeleton of 1 is thermally stable up to 300 °C.",10.1039/c3ce40346g
190,{[Ln2(cpna)3(H2O)3]·4H2O}n<|>Compound 6,ZERNIV,space group,Pˉ1,N/A,Crystallographic analysis,Complex 6 crystallizes in the triclinic space group Pˉ1.,10.1039/C2DT32674D
191,{[Ln2(cpna)3(H2O)3]·4H2O}n<|>Compound 6,ZERNIV,thermal stability,450,°C,Under nitrogen atmosphere,"Compound 6 lost its four lattice water and three coordinated water molecules (exptl, 10.7%; calcd, 10.8%) from 60 to 230 °C, and then decomposition occurs at 450 °C.",10.1039/C2DT32674D
192,{[Ln2(cpna)3(H2O)3]·4H2O}n<|>Compound 7,ZERNUH,density,1.860,g/cm³,Not specified,Dc/g cm−3 1.860,10.1039/C2DT32674D
193,{[Ln2(cpna)3(H2O)3]·4H2O}n<|>Compound 7,ZERNUH,crystal system,Triclinic,None,Not specified,Crystal system Triclinic,10.1039/C2DT32674D
194,{[Ln2(cpna)3(H2O)3]·4H2O}n<|>Compound 7,ZERNUH,cell volume,2084.5,Å³,Not specified,V/Å3 2084.5(6),10.1039/C2DT32674D
195,{[Ln2(cpna)3(H2O)3]·4H2O}n<|>Compound 7,ZERNUH,space group,Pˉ1,None,Not specified,Space group Pˉ1,10.1039/C2DT32674D
196,{[Ln2(cpna)3(H2O)3]·4H2O}n<|>Compound 7,ZERNUH,magnetic susceptibility,23.4,cm³ mol⁻¹ K,2 K,"Upon lowering the temperature, the χMT value decreases continuously to a value of 23.4 cm3 mol−1 K at 2 K.",10.1039/C2DT32674D
197,{[Ln2(cpna)3(H2O)3]·4H2O}n<|>Compound 8,ZERNOB,crystal system,Triclinic,None,None,Complex 6 crystallizes in the triclinic space group Pˉ1.,10.1039/C2DT32674D
198,{[Ln2(cpna)3(H2O)3]·4H2O}n<|>Compound 8,ZERNOB,space group,Pˉ1,None,None,Complex 6 crystallizes in the triclinic space group Pˉ1.,10.1039/C2DT32674D
199,{[Ln2(cpna)3(H2O)3]·4H2O}n<|>Compound 8,ZERNOB,magnetic susceptibility,5.74,cm3 mol−1 K,Temperature range of 2–300 K,χMT value gradually decreases to reach 5.74 cm3 mol−1 K at 2 K.,10.1039/C2DT32674D
200,{[Ln2(cpna)3(H2O)3]·4H2O}n<|>Compound 5,ZERNAN,crystal system,Triclinic,None,None,Complex 6 crystallizes in the triclinic space group Pˉ1.,10.1039/C2DT32674D
201,{[Ln2(cpna)3(H2O)3]·4H2O}n<|>Compound 5,ZERNAN,space group,Pˉ1,None,None,Complex 6 crystallizes in the triclinic space group Pˉ1.,10.1039/C2DT32674D
202,{[Ln2(cpna)3(H2O)3]·4H2O}n<|>Compound 5,ZERNAN,thermal stability,Stable up to 450,°C,Under nitrogen atmosphere,"Compound 6 lost its four lattice water and three coordinated water molecules (exptl, 10.7%; calcd, 10.8%) from 60 to 230 °C, and then decomposition occurs at 450 °C.",10.1039/C2DT32674D
203,{[Sm(Hcpna)(cpna)(phen)]·2H2O}n<|>Compound 4,FICKEJ,crystal system,Triclinic,N/A,N/A,Complex 4 crystallizes in the triclinic space group Pˉ1 and features a 1D wheel-chain structure based on a binuclear unit.,10.1039/C2DT32674D
204,{[Sm(Hcpna)(cpna)(phen)]·2H2O}n<|>Compound 4,FICKEJ,space group,Pˉ1,N/A,N/A,Complex 4 crystallizes in the triclinic space group Pˉ1 and features a 1D wheel-chain structure based on a binuclear unit.,10.1039/C2DT32674D
205,{[Sm(Hcpna)(cpna)(phen)]·2H2O}n<|>Compound 4,FICKEJ,thermal stability,330,°C,Under nitrogen atmosphere,The remaining structure was broken down at 330 °C.,10.1039/C2DT32674D
206,{Cd(L)(BDC)(DMF)}n<|>complex 1,TUBLIN,crystal system,Triclinic,N/A,N/A,"Single crystal X-ray analysis reveals that complex 1 crystallizes in the triclinic system with P1- space group, and exhibits a three dimensional network.",10.1016/j.molstruc.2014.12.014
207,{Cd(L)(BDC)(DMF)}n<|>complex 1,TUBLIN,space group,P1-,N/A,N/A,"Single crystal X-ray analysis reveals that complex 1 crystallizes in the triclinic system with P1- space group, and exhibits a three dimensional network.",10.1016/j.molstruc.2014.12.014
208,{Cd(L)(BDC)(DMF)}n<|>complex 1,TUBLIN,thermal stability,Decomposition at about 350,°C,Under N2 atmosphere,Then the decomposition of the samples occurred at about 350 C.,10.1016/j.molstruc.2014.12.014
209,[Zn3(IDC)2(µ2-H2O)H2O]n<|>Compound 1,MULQOA,density,1.550,none,none specified,TABLE 1 Crystal data for 1 Dcalc 1.550,10.1080/15533170802440755
210,[Zn3(IDC)2(µ2-H2O)H2O]n<|>Compound 1,MULQOA,crystal system,Monoclinic,none,none specified,TABLE 1 Crystal data for 1 Crystal system Monoclinic,10.1080/15533170802440755
211,[Zn3(IDC)2(µ2-H2O)H2O]n<|>Compound 1,MULQOA,cell volume,2674.94(10),Å³,none specified,TABLE 1 Crystal data for 1 V (A˚ 3) 2674.94(10),10.1080/15533170802440755
212,[Zn3(IDC)2(µ2-H2O)H2O]n<|>Compound 1,MULQOA,space group,P21/n,none,none specified,"X-ray crystallography reveals that compound 1 crystallizes in a central symmetrical space group, P21/n.",10.1080/15533170802440755
213,[Zn3(IDC)2(µ2-H2O)H2O]n<|>Compound 1,MULQOA,molecular weight,624.35,g mol−1,none specified,TABLE 1 Crystal data for 1 Formula C10H12N4O15Zn3 M (g mol−1) 624.35,10.1080/15533170802440755
214,[Zn3(IDC)2(µ2-H2O)H2O]n<|>Compound 1,MULQOA,thermal stability,stable up to 320,°C,none specified,"there is no other weight loss before 320◦C, indicating the presence of a stable dehydrated framework over a wide range of temperatures.",10.1080/15533170802440755
215,Cd(mip)(DMF)<|>Compound 1,NAPZOV,chemical formula,C12H13CdNO5,N/A,N/A,Compound 1 Empirical formula C12H13CdNO5,10.1016/j.solidstatesciences.2011.12.002
216,Cd(mip)(DMF)<|>Compound 1,NAPZOV,density,1.847,g cm3,N/A,Compound 1 rcalcd(g cm3 ) 1.847,10.1016/j.solidstatesciences.2011.12.002
217,Cd(mip)(DMF)<|>Compound 1,NAPZOV,crystal system,Orthorhombic,N/A,N/A,Compound 1 Cryst syst Orthorhombic,10.1016/j.solidstatesciences.2011.12.002
218,Cd(mip)(DMF)<|>Compound 1,NAPZOV,cell volume,1307.9(7),Å3,N/A,Compound 1 V (Å3 ) 1307.9(7),10.1016/j.solidstatesciences.2011.12.002
219,Cd(mip)(DMF)<|>Compound 1,NAPZOV,space group,Pna21,N/A,N/A,Compound 1 Space group Pna21,10.1016/j.solidstatesciences.2011.12.002
220,Cd(mip)(DMF)<|>Compound 1,NAPZOV,molecular weight,363.63,N/A,N/A,Compound 1 Fw 363.63,10.1016/j.solidstatesciences.2011.12.002
221,Cd(mip)(EtOH)<|>Compound 2,NAPZUB,chemical formula,C11H12CdO5,N/A,N/A,Empirical formula C11H12CdO5,10.1016/j.solidstatesciences.2011.12.002
222,Cd(mip)(EtOH)<|>Compound 2,NAPZUB,density,1.794,g cm3,N/A,rcalcd(g cm3 ) 1.794,10.1016/j.solidstatesciences.2011.12.002
223,Cd(mip)(EtOH)<|>Compound 2,NAPZUB,crystal system,Orthorhombic,N/A,N/A,Cryst syst Orthorhombic,10.1016/j.solidstatesciences.2011.12.002
224,Cd(mip)(EtOH)<|>Compound 2,NAPZUB,cell volume,1242.5(4),Å3,N/A,V (Å3 ) 1242.5(4),10.1016/j.solidstatesciences.2011.12.002
225,Cd(mip)(EtOH)<|>Compound 2,NAPZUB,space group,Pna21,N/A,N/A,Space group Pna21,10.1016/j.solidstatesciences.2011.12.002
226,{[Zn(ata)0.5(DMF)(H2O)] 3 DMF 3 H2O}n<|>1,QUDJEF,crystal system,Monoclinic,N/A,Room temperature,X-ray crystallographic analysis revealed that 1 crystallizes in monoclinic space group P21/c.,10.1021/cg900659r
227,{[Zn(ata)0.5(DMF)(H2O)] 3 DMF 3 H2O}n<|>1,QUDJEF,space group,P21/c,N/A,Room temperature,X-ray crystallographic analysis revealed that 1 crystallizes in monoclinic space group P21/c.,10.1021/cg900659r
228,"{[Zn(ata)0.5(4,40-bipy)0.5(DMF)] 3 DMF}n<|>2",QUDJIJ,crystal system,Monoclinic,N/A,N/A,"The asymmetric unit of 2 was composed of one ZnII ion, half ata4-, half 4,40-bipy, one coordinated DMF, and one free DMF molecule.",10.1021/cg900659r
229,"{[Zn(ata)0.5(4,40-bipy)0.5(DMF)] 3 DMF}n<|>2",QUDJIJ,space group,P21/c,N/A,N/A,"The asymmetric unit of 2 was composed of one ZnII ion, half ata4-, half 4,40-bipy, one coordinated DMF, and one free DMF molecule.",10.1021/cg900659r
230,"{[Zn(ata)0.5(4,40-bipy)0.5(DMF)] 3 DMF}n<|>2",QUDJIJ,thermal stability,"Stable up to 70, weight loss of 14.06% below 230","°C, %",N/A,Complex 2 is stable up to 70 C and shows a weight loss of 14.06% below 230 C. That result is slightly lower than the calculated value for the loss of DMF (15.73%) and might be attributed to the decomposition of DMF.,10.1021/cg900659r
231,"{[Zn(ata)0.5(4,40-bipy)0.5(DMF)] 3 DMF}n<|>2",QUDJIJ,topology,"3,4-connected net with stoichiometry (3-c)2(4-c)",N/A,N/A,"Topology analysis of the framework gave a 3,4-connected net with stoichiometry (3-c)2(4-c) while ZnII ions as 3-connected nodes and ata4- ligands as 4-connected nodes. The total Schlafli symbol was given as {83}2{85; 10}.",10.1021/cg900659r
232,Mn-FPAA-1,OTIPUE,crystal system,Monoclinic,Not applicable,Not specified,Mn-FPAA-1 monoclinic P21/c 337 0.97,10.1021/acs.inorgchem.6b00758
233,Mn-FPAA-1,OTIPUE,thermal stability,Beyond 300,°C,Not specified,TGA performed on as-synthesized Mn-PAA-1 and Mn-FPAA-1 revealed that these compounds have high thermal stability beyond 300 °C (Figure S21).,10.1021/acs.inorgchem.6b00758
234,Mn-FPAA-1,OTIPUE,surface area,337,m2 g−1,Not specified,The higher surface area of Mn-PAA-1 (610 m2 g−1) than that of Mn-FPAA-1 (337 m2 g−1) can be attributed to the higher pore dimensions and solvent-accessible voids (Figure S20).,10.1021/acs.inorgchem.6b00758
235,Mn-PAA-1,OTIQAL,crystal system,Monoclinic,Not applicable,Not specified,Mn-PAA-1 monoclinic P21/c 610 1.09,10.1021/acs.inorgchem.6b00758
236,Mn-PAA-1,OTIQAL,thermal stability,Beyond 300,°C,Not specified,TGA performed on as-synthesized Mn-PAA-1 and Mn-FPAA-1 revealed that these compounds have high thermal stability beyond 300 °C (Figure S21).,10.1021/acs.inorgchem.6b00758
237,Mn-PAA-1,OTIQAL,surface area,610,m2 g−1,Not specified,The higher surface area of Mn-PAA-1 (610 m2 g−1) than that of Mn-FPAA-1 (337 m2 g−1) can be attributed to the higher pore dimensions and solvent-accessible voids (Figure S20).,10.1021/acs.inorgchem.6b00758
238,Co-FPAA-1,OTOVIE,crystal system,Monoclinic,Not applicable,Not specified,Co-FPAA-1 monoclinic P21/c,10.1021/acs.inorgchem.6b00758
239,Co-FPAA-1,OTOVIE,surface area,449,m2 g−1,Not specified,"However, because of its rigid structure and larger pores, Co-FPAA-1 has a BET surface area of 449 m2 g−1, which is higher than its nonfluorinated isomer (Co-PAA1).",10.1021/acs.inorgchem.6b00758
240,Cd-FPAA-1,OTOVAW,crystal system,Monoclinic,Not applicable,Not specified,"""Cd-FPAA-1 monoclinic P21/c 298 1.20 a Reported in the literature.""",10.1021/acs.inorgchem.6b00758
241,Cd-FPAA-1,OTOVAW,surface area,298,m2 g−1,Not specified,"""Cd-PAA-1 has a higher surface area than Cd-FPAA-1 because the former has larger pores with higher solvent-accessible voids (Table 1).""",10.1021/acs.inorgchem.6b00758
242,Cd-PAA-1,OTIPAK,crystal system,Orthorhombic,Not applicable,Not specified,"""Cd-PAA-1 orthorhombic Pnna 795 1.30""",10.1021/acs.inorgchem.6b00758
243,Cd-PAA-1,OTIPAK,surface area,795,m2 g−1,Not specified,"""Cd-PAA-1 has a higher surface area than Cd-FPAA-1 because the former has larger pores with higher solvent-accessible voids (Table 1).""",10.1021/acs.inorgchem.6b00758
244,Mn-INA-1,OTIQEP,crystal system,Monoclinic,N/A,N/A,"The crystal structures of Mn-, Co-, and Cd-based MOFs comprised of INA and FINA linkers are determined using single-crystal X-ray diffraction analyses (Figures 1 and 2).",10.1021/acs.inorgchem.6b00758
245,Mn-INA-1,OTIQEP,space group,P21,N/A,N/A,Table 1. Summary of the Structural Information of MOFs with Their Porosity Details space surface area (m2 g−1 ) H2 uptake MOF cryst syst group (wt %) Mn-INA-1 monoclinic P21,10.1021/acs.inorgchem.6b00758
246,1[Cd2Cl2(Me-3py-trz-pba)2]<|>4,PUFVUJ,crystal system,Monoclinic,N/A,N/A,4–6 crystallize in the monoclinic space group C2/c (no. 15) with four formula units per unit cell.,10.1002/chem.201405395
247,1[Cd2Cl2(Me-3py-trz-pba)2]<|>4,PUFVUJ,space group,C2/c,N/A,N/A,4–6 crystallize in the monoclinic space group C2/c (no. 15) with four formula units per unit cell.,10.1002/chem.201405395
248,1[Cd2Cl2(Me-3py-trz-pba)2]<|>4,PUFVUJ,thermal stability,Up to 450,°C,According to TG curves,The thermal stability of 4–6 (up to 430–450°C) according to TG curves is in good agreement with the results from temperature-dependent PXRD.,10.1002/chem.201405395
249,1[Cd2Br2(Me-3py-trz-pba)2]<|>5,PUFWEU,space group,C2/c,N/A,Not specified,These compounds were synthesized by solvothermal reactions of the protonated ligand and the respective cadmium halides. 4–6 crystallize in the monoclinic space group C2/c (no. 15) with four formula units per unit cell.,10.1002/chem.201405395
250,1[Cd2Br2(Me-3py-trz-pba)2]<|>5,PUFWEU,thermal stability,430–450,°C,According to TG curves,The thermal stability of 4–6 (up to 430–450°C) according to TG curves is in good agreement with the results from temperature-dependent PXRD.,10.1002/chem.201405395
251,1[Cd2I2(Me-3py-trz-pba)2]<|>6,PUFWOE,crystal system,Monoclinic,N/A,Not specified,4–6 crystallize in the monoclinic space group C2/c (no. 15) with four formula units per unit cell.,10.1002/chem.201405395
252,1[Cd2I2(Me-3py-trz-pba)2]<|>6,PUFWOE,space group,C2/c,N/A,Not specified,4–6 crystallize in the monoclinic space group C2/c (no. 15) with four formula units per unit cell.,10.1002/chem.201405395
253,1[Cd2I2(Me-3py-trz-pba)2]<|>6,PUFWOE,thermal stability,Up to 450,°C,According to TG curves,The thermal stability of 4–6 (up to 430–4508C) according to TG curves is in good agreement with the results from temperature-dependent PXRD.,10.1002/chem.201405395
254,"1[Cd{(pym-NH2)2ph}(1,2-bdc)]<|>22",PUGCAX,thermal stability,up to 440,°C,N/A,Several frameworks are porous with calculated porosity up to 64% and thermal stability up to 4408C.,10.1002/chem.201405395
255,"1[Cd{(pym-NH2)2ph}(1,2-bdc)]<|>22",PUGCAX,porosity,up to 64,%,N/A,Several frameworks are porous with calculated porosity up to 64% and thermal stability up to 4408C.,10.1002/chem.201405395
256,"1[Cd{(pym-NH2)2ph}(1,2-bdc)]<|>22",PUGCAX,topology,N/A,N/A,N/A,"This series of Cd2+-based coordination polymers shows a large variety of different types of connectivity, with dia, alb, crb, atb, sql, and cem topology.",10.1002/chem.201405395
257,[Zn4(L)2(μ4-O)(H2O)2(DMF)]n<|>compound 1,DITTEH,thermal stability,350,°C,Under N2 atmosphere with a heating rate of 10 °C/min,"Then, the skeleton of 1 can be stable up to 350 °C.",10.1016/j.inoche.2013.07.001
258,"{[Cd2(L1)(μ1,1-N3)2(μ1,3-N3)(N3)] (H2O)1.5}n<|>2",XUYDIF,topology,(3.4.5.83)(3.42.5.62)(3.43.52.62.72),N/A,N/A,"""As a result, a three-nodal (4,5)-connected framework with the Schläfli symbol of (3.4.5.83)(3.42.5.62)(3.43.52.62.72) is constructed.""",10.1016/j.inoche.2010.04.015
259,Dy2(INO)4(NO3)2<|>Dy2 A,not provided,magnetic susceptibility,31.66,cm³Kmol⁻¹,Temperature range 2–300 K under an applied field of 1 kOe,The increases in cM T at very low temperature suggest that ferromagnetic coupling starts to dominate the magnetic behavior for the ground state of each material.,10.1002/anie.201503636
260,CPM-41<|>Li2(OPy)2(DMF)2,BUKXUC,crystal system,monoclinic,N/A,N/A,CPM-41 crystallizes in a chiral monoclinic P21 space group and has a layered structure constructed by cross-linking Li2 dimers with -OPy ligand.,10.1021/acs.cgd.5b00358
261,CPM-41<|>Li2(OPy)2(DMF)2,BUKXUC,cell volume,939.4,Å3,N/A,"V, Å3 939.4(3)",10.1021/acs.cgd.5b00358
262,CPM-41<|>Li2(OPy)2(DMF)2,BUKXUC,space group,P21,N/A,N/A,CPM-41 crystallizes in a chiral monoclinic P21 space group and has a layered structure constructed by cross-linking Li2 dimers with -OPy ligand.,10.1021/acs.cgd.5b00358
263,CPM-42<|>[Li2(OPy)2(diox)]·(diox),BUKYAJ,crystal system,monoclinic,N/A,N/A,CPM-42 with formula of [Li2(OPy)2(diox)]·(diox) was obtained. Figure 2 Figure 2. An illustration showing how the Li2(OPy)2 layers are pillared by dioxane linkers in CPM-42 (the guest dioxane is not shown).,10.1021/acs.cgd.5b00358
264,CPM-42<|>[Li2(OPy)2(diox)]·(diox),BUKYAJ,cell volume,1044.72,Å3,N/A,"formulaa Li2(OPy)2(DMF)2 [Li2(OPy)2(diox)]·(diox) FW 348.26 378.27 crystal system monoclinic monoclinic space group P21 P21/c a, Å 9.424(2) 7.1555(2) b, Å 10.634(2) 12.4238(3) c, Å 9.4807(18) 11.7575(3) α, deg 90 90 β, deg 98.611(16) 91.7820(10) γ, deg 90 90 V, Å3 939.4(3) 1044.72(5)",10.1021/acs.cgd.5b00358
265,CPM-42<|>[Li2(OPy)2(diox)]·(diox),BUKYAJ,space group,P21/c,N/A,N/A,formulaa Li2(OPy)2(DMF)2 [Li2(OPy)2(diox)]·(diox) FW 348.26 378.27 crystal system monoclinic monoclinic space group P21 P21/c,10.1021/acs.cgd.5b00358
266,{Er2(DHBDC)3(DMF)42}n<|>compound 5,ETEKEU,chemical formula,C42H54Er2N6O24,N/A,N/A,"Compound 5: 3463 (vs), 1642 (s), 1506 (w), 1455 (m), 1384 (s), 1258 (w), 1144 (s), 1088 (s), 990 (w), 947 (w), 857 (m), 790 (w), 596 (w), 545 (m), 516 (m). Anal. Calcd for C42H54Er2N6O24 (1361.43) (5): C, 37.05; H, 4.00; N, 6.17%.",10.1039/c1ce05069a
267,{Er2(DHBDC)3(DMF)42}n<|>compound 5,ETEKEU,density,1.715,g cm-3,N/A,Crystal system Triclinic Triclinic Space group P1 P1 Z 1 1 a/A 10.5226(9) 10.5507(9) b/A 11.0545(9) 10.9265(10) c/A 12.7711(11) 12.8978(11) a ( ) 103.8260(10) 103.1840(10) b ( ) 110.0240(10) 111.1470(10) g ( ) 96.6020(10) 96.5660(10) V/A3 1323.41(19) 1318.2(2) Dc/g cm3 1.683 1.715 m/mm1 2.570 3.248 Measured reflections 12 457 8303 Independent reflections 6361 6100 Observed reflections [I > 2s(I)] 5454 5363 R[int] 0.0246 0.0204 R1[obsd. refl.] 0.0348 0.0363 wR2[all refl.] 0.0923 0.0870 a R1 ¼ SkFo Fck/S Fo,10.1039/c1ce05069a
268,{Er2(DHBDC)3(DMF)42}n<|>compound 5,ETEKEU,crystal system,Triclinic,N/A,N/A,Crystal system Triclinic Triclinic Space group P1 P1 Z 1 1 a/A 10.5226(9) 10.5507(9) b/A 11.0545(9) 10.9265(10) c/A 12.7711(11) 12.8978(11) a ( ) 103.8260(10) 103.1840(10) b ( ) 110.0240(10) 111.1470(10) g ( ) 96.6020(10) 96.5660(10) V/A3 1323.41(19) 1318.2(2) Dc/g cm3 1.683 1.715 m/mm1 2.570 3.248 Measured reflections 12 457 8303 Independent reflections 6361 6100 Observed reflections [I > 2s(I)] 5454 5363 R[int] 0.0246 0.0204 R1[obsd. refl.] 0.0348 0.0363 wR2[all refl.] 0.0923 0.0870 a R1 ¼ SkFo Fck/S Fo,10.1039/c1ce05069a
269,{Er2(DHBDC)3(DMF)42}n<|>compound 5,ETEKEU,space group,P1,N/A,N/A,Crystal system Triclinic Triclinic Space group P1 P1 Z 1 1 a/A 10.5226(9) 10.5507(9) b/A 11.0545(9) 10.9265(10) c/A 12.7711(11) 12.8978(11) a ( ) 103.8260(10) 103.1840(10) b ( ) 110.0240(10) 111.1470(10) g ( ) 96.6020(10) 96.5660(10) V/A3 1323.41(19) 1318.2(2) Dc/g cm3 1.683 1.715 m/mm1 2.570 3.248 Measured reflections 12 457 8303 Independent reflections 6361 6100 Observed reflections [I > 2s(I)] 5454 5363 R[int] 0.0246 0.0204 R1[obsd. refl.] 0.0348 0.0363 wR2[all refl.] 0.0923 0.0870 a R1 ¼ SkFo Fck/S Fo,10.1039/c1ce05069a
270,{Sm2(DHBDC)3(DMF)42}n<|>compound 3,ETEJUJ,chemical formula,C42H54Sm2N6O24,none,none,"Compound 3: 3462 (vs), 1645 (s), 1504 (m), 1455 (s), 1339 (s), 1258 (m), 1139 (s), 1087 (s), 996 (w), 866 (m), 819 (m), 790 (m), 540 (m). Anal. Calcd for C42H54Sm2N6O24 (1327.61) (3): C, 38.00; H, 4.10; N, 6.33%.",10.1039/c1ce05069a
271,{Sm2(DHBDC)3(DMF)42}n<|>compound 3,ETEJUJ,density,1.661,g cm3,none,Dc/g cm3 1.598 1.632 1.661,10.1039/c1ce05069a
272,{Sm2(DHBDC)3(DMF)42}n<|>compound 3,ETEJUJ,crystal system,Triclinic,none,none,Crystal system Triclinic Triclinic Triclinic,10.1039/c1ce05069a
273,{Sm2(DHBDC)3(DMF)42}n<|>compound 3,ETEJUJ,cell volume,1327.53,A3,none,V/A3 1355.4(9) 1338.2(6) 1327.53(11),10.1039/c1ce05069a
274,{Sm2(DHBDC)3(DMF)42}n<|>compound 3,ETEJUJ,space group,P1,none,none,Space group P1 P1 P1,10.1039/c1ce05069a
275,{Nd2(DHBDC)3(DMF)42}n<|>compound 2,ETEJOD,chemical formula,C42H54O24N6Nd2,N/A,N/A,Empirical formula C42H54O24N6Nd2,10.1039/c1ce05069a
276,{Nd2(DHBDC)3(DMF)42}n<|>compound 2,ETEJOD,density,1.632,g cm3,N/A,Dc/g cm3 1.632,10.1039/c1ce05069a
277,{Nd2(DHBDC)3(DMF)42}n<|>compound 2,ETEJOD,crystal system,Triclinic,N/A,N/A,Crystal system Triclinic,10.1039/c1ce05069a
278,{Nd2(DHBDC)3(DMF)42}n<|>compound 2,ETEJOD,cell volume,1338.2,A3,N/A,V/A3 1338.2(6),10.1039/c1ce05069a
279,{Nd2(DHBDC)3(DMF)42}n<|>compound 2,ETEJOD,space group,P1,N/A,N/A,Space group P1,10.1039/c1ce05069a
280,{La2(DHBDC)3(DMF)42}n<|>compound 1,ETEJIX,chemical formula,C42H54La2N6O24,N/A,N/A,"A series of isomorphous lanthanide coordination polymers with the empirical formula {Ln2(DHBDC)3(DMF)42}n (Ln ¼ La(1), Nd(2), Sm(3), Gd(4), and Er(5)) were isolated.",10.1039/c1ce05069a
281,{La2(DHBDC)3(DMF)42}n<|>compound 1,ETEJIX,density,1.598,g cm3,N/A,Dc/g cm3 1.598,10.1039/c1ce05069a
282,{La2(DHBDC)3(DMF)42}n<|>compound 1,ETEJIX,crystal system,Triclinic,N/A,N/A,Crystal system Triclinic,10.1039/c1ce05069a
283,{La2(DHBDC)3(DMF)42}n<|>compound 1,ETEJIX,cell volume,1355.4,A3,N/A,V/A3 1355.4(9),10.1039/c1ce05069a
284,{La2(DHBDC)3(DMF)42}n<|>compound 1,ETEJIX,space group,P1,N/A,N/A,Space group P1,10.1039/c1ce05069a
285,{[Tb2(HIDC)3(H2O)2]·7H2O}n<|>Complex 1,UYOFIY,space group,Pbca,N/A,Crystallization,Complex 1 crystallizes in the orthorhombic space group Pbca.,10.1016/j.inoche.2011.02.021
286,(choline)[Yb(bdc)2(urea)]<|>compound 2,SUNHEP,space group,P1¯,N/A,N/A,Compound Formula Space group a [] b [] c [] a [ o ] b [ o ] g [ o ] R(F) 2 (choline)[Yb(bdc)2(urea)] P1¯ 8.4034(1) 10.5334(1) 14.3515(1) 100.83(1) 103.41(1) 101.56(1) 0.0191,10.1002/anie.200900134
287,(choline)[Sm(bdc)2(urea)]<|>compound 2a,SUNHIT,space group,P1¯,N/A,N/A,Space group: P1¯,10.1002/anie.200900134
288,(choline)[Y(bdc)2(urea)]<|>compound 2b,SUNHOZ,space group,P1¯,N/A,N/A,"""Compound Formula Space group a [] b [] c [] a [ o ] b [ o ] g [ o ] R(F) 2 (choline)[Yb(bdc)2(urea)] P1¯ 8.4034(1) 10.5334(1) 14.3515(1) 100.83(1) 103.41(1) 101.56(1) 0.0191 2 a (choline)[Sm(bdc)2(urea)] P1¯ 8.3898(1) 10.6559(2) 14.3877(2) 101.964(1) 102.864(1) 102.681(1) 0.0206 2 b (choline)[Y(bdc)2(urea)] P1¯ 8.3734(2) 10.5740(2) 14.3077(3) 101.478(1) 103.120(1) 102.247(1) 0.0390""",10.1002/anie.200900134
289,[Nd(bdc)2(choline)]·(m-urea)<|>compound 3,SUNHUF,space group,P21/n,N/A,N/A,"""3 [Nd(bdc)2(choline)]·(m-urea) P21/n 14.4400(3) 12.2290(2) 14.5152(3) 90.00 104.657(1) 90.00 0.0482""",10.1002/anie.200900134
290,[Yb2(bdc)3(e-urea)4]<|>compound 5,SUNJER,space group,P1¯,N/A,N/A,5 [Yb2(bdc)3(e-urea)4] P1¯ 9.7863(7) 10.2967(7) 11.0263(7) 76.898(5) 76.240(5) 65.487(5) 0.0301,10.1002/anie.200900134
291,[Dy2(bdc)3(e-urea)4]<|>compound 5a,SUNJIV,space group,P1¯,N/A,N/A,5 a [Dy2(bdc)3(e-urea)4] P1¯ 9.8283(1) 10.4362(1) 11.0760(1) 76.894(1) 76.296(1) 65.999(1) 0.0158,10.1002/anie.200900134
292,[Ho2(bdc)3(e-urea)4]<|>compound 5b,SUNJOB,space group,P1¯,N/A,N/A,5 b [Ho2(bdc)3(e-urea)4] P1¯ 9.8113(2) 10.4188(2) 11.0768(2) 76.721(1) 76.242(1) 65.932(1) 0.0176,10.1002/anie.200900134
293,{Zn(p-bdc)(bix)2}n<|>compound 1,YARDEC,crystal system,Monoclinic,N/A,N/A,"Compound 1 crystallizes in the monoclinic system, space group C2/c.",10.1021/cg201025u
294,{Zn(p-bdc)(bix)2}n<|>compound 1,YARDEC,space group,C2/c,N/A,N/A,"Compound 1 crystallizes in the monoclinic system, space group C2/c.",10.1021/cg201025u
295,{Co(p-bdc)(bix)2}n<|>compound 2,YARDIG,crystal system,Monoclinic,N/A,N/A,"Compound 2 crystallizes in the monoclinic system, space group C2/c.",10.1021/cg201025u
296,{Co(p-bdc)(bix)2}n<|>compound 2,YARDIG,space group,C2/c,N/A,N/A,"Compound 2 crystallizes in the monoclinic system, space group C2/c.",10.1021/cg201025u
297,{Co(p-bdc)(bix)2}n<|>compound 2,YARDIG,topology,dia topological type,N/A,N/A,Isostructural complexes 1 and 2 reveal a 3-fold interpenetrating three-dimensional (3D) framework with dia topological type.,10.1021/cg201025u
298,{[Cd(DPA)(bix)]1.75(H2O)}n<|>complex 1,KATDAM,space group,P61,N/A,Crystallization conditions,X-Ray crystal structure analysis reveals that complex 1 crystallizes in a chiral hexagonal space group P61.,10.1039/c2cc16779d
299,{[Cd2(bte)2(btec)(H2O)2]·11H2O}n<|>6,ZIYQAB,density,1.742,g cm−3,None,Table 2 Crystal data and structure refinement for 6–9 6 7 8 9 ρcalc (g cm−3 ) 1.742 1.704 1.942 2.020,10.1039/C3CE42189A
300,{[Cd2(bte)2(btec)(H2O)2]·11H2O}n<|>6,ZIYQAB,crystal system,Monoclinic,None,None,Table 2 Crystal data and structure refinement for 6–9 6 7 8 9 Crystal system Monoclinic Orthorhombic Triclinic Triclinic,10.1039/C3CE42189A
301,{[Cd2(bte)2(btec)(H2O)2]·11H2O}n<|>6,ZIYQAB,cell volume,1978.5,Å3,None,Table 2 Crystal data and structure refinement for 6–9 6 7 8 9 V (Å3 ) 1978.5(6) 2138.9(3) 782.8(3) 1006.1(5),10.1039/C3CE42189A
302,{[Cd2(bte)2(btec)(H2O)2]·11H2O}n<|>6,ZIYQAB,space group,P21/n,None,None,Table 2 Crystal data and structure refinement for 6–9 6 7 8 9 Space group P21/n Pbcn P¯1 P¯1,10.1039/C3CE42189A
303,{[Cd2(bte)2(btec)(H2O)2]·11H2O}n<|>6,ZIYQAB,molecular weight,1037.49,None,None,Table 2 Crystal data and structure refinement for 6–9 6 7 8 9 Formula C22H44Cd2N12O21 C20H16CdN6O6 C11H13CdN4O9 C28H30Cd3N12O18S2 Fw 1037.49,10.1039/C3CE42189A
304,"{[Cd(bte)0.5(1,4-bdc)(H2O)]·2H2O}n<|>5",ZIYPUU,density,1.689,g cm−3,N/A,ρcalc (g cm−3 ) 1.689,10.1039/C3CE42189A
305,"{[Cd(bte)0.5(1,4-bdc)(H2O)]·2H2O}n<|>5",ZIYPUU,crystal system,Triclinic,N/A,N/A,Crystal system Triclinic,10.1039/C3CE42189A
306,"{[Cd(bte)0.5(1,4-bdc)(H2O)]·2H2O}n<|>5",ZIYPUU,cell volume,811.2,Å³,N/A,V (Å3 ) 811.2(2),10.1039/C3CE42189A
307,"{[Cd(bte)0.5(1,4-bdc)(H2O)]·2H2O}n<|>5",ZIYPUU,space group,P¯1,N/A,N/A,Space group P¯1,10.1039/C3CE42189A
308,"{[Cd(bte)0.5(1,4-bdc)(H2O)]·2H2O}n<|>5",ZIYPUU,molecular weight,412.65,N/A,N/A,Fw 412.65,10.1039/C3CE42189A
309,"{[Cd(bte)0.5(1,4-bdc)(H2O)]·2H2O}n<|>5",ZIYPUU,thermal stability,Stable up to 240,°C,N/A,"The network is thermally stable upon heating to 240 °C and then the continuous weight loss occurred, which did not end until 600 °C.",10.1039/C3CE42189A
310,[Co2(ctpy)2(ox)]n-2.5nH2O<|>compound 1,DUBJUH,chemical formula,C17H10CoN3O5.25,None,None specified,Crystallographic data and structural refinement parameters for 1–4. a Complexes 1 2 3 4 Empirical formula C17H10CoN3O5.25 C17H10N3NiO5.25 C38H32Co2N6O10 C24H17CoN3O7,10.1016/j.ica.2015.02.010
311,[Co2(ctpy)2(ox)]n-2.5nH2O<|>compound 1,DUBJUH,crystal system,Monoclinic,None,None specified,X-ray single crystal structural analysis reveals that compounds 1 and 2 crystallize in the monoclinic system with C2/m space group and are isostructural with previously reported zinc complex [25].,10.1016/j.ica.2015.02.010
312,[Co2(ctpy)2(ox)]n-2.5nH2O<|>compound 1,DUBJUH,cell volume,4605.2(8),Å³,None specified,Crystallographic data and structural refinement parameters for 1–4. a Complexes 1 2 3 4 V (Å3 ) 4605.2(8) 4546.7(7) 3453(2) 2139.7(7),10.1016/j.ica.2015.02.010
313,[Co2(ctpy)2(ox)]n-2.5nH2O<|>compound 1,DUBJUH,space group,C2/m,None,None specified,X-ray single crystal structural analysis reveals that compounds 1 and 2 crystallize in the monoclinic system with C2/m space group and are isostructural with previously reported zinc complex [25].,10.1016/j.ica.2015.02.010
314,[Ni2(ctpy)2(ox)]n-2.5nH2O<|>compound 2,DUBKAO,chemical formula,C17H10N3NiO5.25,N/A,N/A,Crystallographic data and structural refinement parameters for 1–4. a Complexes 1 2 3 4 Empirical formula C17H10CoN3O5.25 C17H10N3NiO5.25 C38H32Co2N6O10 C24H17CoN3O7,10.1016/j.ica.2015.02.010
315,[Ni2(ctpy)2(ox)]n-2.5nH2O<|>compound 2,DUBKAO,crystal system,Monoclinic,N/A,N/A,X-ray single crystal structural analysis reveals that compounds 1 and 2 crystallize in the monoclinic system with C2/m space group and are isostructural with previously reported zinc complex [25].,10.1016/j.ica.2015.02.010
316,[Ni2(ctpy)2(ox)]n-2.5nH2O<|>compound 2,DUBKAO,space group,C2/m,N/A,N/A,X-ray single crystal structural analysis reveals that compounds 1 and 2 crystallize in the monoclinic system with C2/m space group and are isostructural with previously reported zinc complex [25].,10.1016/j.ica.2015.02.010
317,[Ni2(ctpy)2(ox)]n-2.5nH2O<|>compound 2,DUBKAO,thermal stability,Stable up to 310,°C,N/A,The TGA curve of 2 reveals that the weight loss of 5.25% below 310 C (calculated: 5.64%) corresponds to the loss of one guest water molecule.,10.1016/j.ica.2015.02.010
318,{Cu4[(C57H32N12)(COO)8]}n<|>1,QAGDIO,surface area,2436,m2 g-1,77 K,"The overall N2 uptake of 1 is 655 cm3 g-1 at 1 atm, and its Brunauer-Emmett-Teller (BET) surface area was calculated to be 2436 m2 g-1 (Figure S5 in the SI), which is comparable with reported MOFs having similar structures such as NTU-11112b and ZJU-5.14b",10.1021/jacs.5b13335
319,{[NiSr(C3H2O4)2(H2O)5]-2H2O}n,FOHSAW01,crystal system,Monoclinic,None,Not specified,"Crystal data [NiSr(C3H2O4)2(H2O)5]2H2O Mr = 476.53 Monoclinic, P21=c.",10.1107/S1600536810049779
320,[Zn(muco)(bpee)]·4H2O<|>compound 2,QIVYUR,crystal system,Monoclinic,N/A,N/A,Compound 2 crystallizes in the monoclinic crystal system with the C2/c space group.,10.1039/C3CE42454E
321,[Zn(muco)(bpee)]·4H2O<|>compound 2,QIVYUR,space group,C2/c,N/A,N/A,Compound 2 crystallizes in the monoclinic crystal system with the C2/c space group.,10.1039/C3CE42454E
322,[Zn(muco)(bpee)]·4H2O<|>compound 2,QIVYUR,thermal stability,Stable up to 240,°C,N/A,"Compound 2 shows a weight loss of ~8.0% around 80–180 °C which corresponds to the loss of two guest water molecules (calc. wt% 8.4) (Fig. S3, ESI†) and the dehydrated framework, [Zn(muco)(bpee)]n, is stable up to 240 °C.",10.1039/C3CE42454E
323,[Zn(muco)(bpee)]·4H2O<|>compound 2,QIVYUR,topology,Diamondoid (dia) net topology,N/A,N/A,Topological analysis by TOPOS23 suggests that each Zn(II) center acts as a 4-connecting node and the overall structure has the diamondoid (dia) net topology with the Schläfli point symbol {66}.,10.1039/C3CE42454E
324,[Zn(muco)(3bpdh)]<|>compound 3,QIVZAY,crystal system,Monoclinic,N/A,X-ray structure determination,Compound 3 crystallizes in the monoclinic crystal system with the C2/c space group.,10.1039/C3CE42454E
325,[Zn(muco)(3bpdh)]<|>compound 3,QIVZAY,space group,C2/c,N/A,X-ray structure determination,Compound 3 crystallizes in the monoclinic crystal system with the C2/c space group.,10.1039/C3CE42454E
326,[Zn(muco)(3bpdh)]<|>compound 3,QIVZAY,topology,3D diamondoid (dia) structure with 3-fold interpenetrated nets,N/A,N/A,"Compounds 2 and 3 have 3D diamondoid (dia) structures with interesting 5-fold and 3-fold interpenetrated nets, respectively.",10.1039/C3CE42454E
327,[Zn2(muco)2(azopy)2]·3DMF·2H2O<|>compound 1,QIWBAB,crystal system,Orthorhombic,N/A,X-ray crystallography analysis,"Compound 1 crystallizes in the orthorhombic crystal system with the non-centrosymmetric, Pca21 space group.",10.1039/C3CE42454E
328,[Zn2(muco)2(azopy)2]·3DMF·2H2O<|>compound 1,QIWBAB,space group,Pca21,N/A,X-ray crystallography analysis,"Compound 1 crystallizes in the orthorhombic crystal system with the non-centrosymmetric, Pca21 space group.",10.1039/C3CE42454E
329,[Zn4(muco)4(4bpdh)4]·4bpdh·2H2O<|>compound 4,QIVZEC,crystal system,Triclinic,N/A,Determined by X-ray crystallography.,"Compound 4 has a 3D cubic (pcu, α-Po) structure with a 2-fold interpenetrating net.",10.1039/C3CE42454E
330,[Zn4(muco)4(4bpdh)4]·4bpdh·2H2O<|>compound 4,QIVZEC,space group,P¯1,(no. 2),Determined by X-ray crystallography.,"Compound 4 has a 3D cubic (pcu, α-Po) structure with a 2-fold interpenetrating net.",10.1039/C3CE42454E
331,[Zn4(muco)4(4bpdh)4]·4bpdh·2H2O<|>compound 4,QIVZEC,topology,{412·63},N/A,Determined by topological analysis.,"Compound 4 has a 3D cubic (pcu, α-Po) structure with a 2-fold interpenetrating net with {412·63} net topology.",10.1039/C3CE42454E
332,[Gd2Cu3(IDA)6]3 nH2O<|>Gd crystal,IBATEM,cell volume,2253.9,Å3,at 273 K,"Lattice constants at 273 K: Gd, a = 13.415(1) Å, c = 14.462(1) Å, V = 2253.9 Å3;",10.1021/ja200978u
333,[La2Cu3(IDA)6]3 nH2O<|>La crystal,IBASEL,cell volume,2335.0,Å3,at 273 K,"Lattice constants at 273 K: Gd, a = 13.415(1) Å, c = 14.462(1) Å, V = 2253.9 Å3; La (water-free), a = 13.461(1) Å, c = 14.881(1) Å, V = 2335.0 Å3.",10.1021/ja200978u
334,[Nd2Cu3(IDA)6]3 nH2O<|>Nd crystal,IBASOV,space group,P3c1,None,General structural property,X-ray diffraction experiments showed that all these crystals of [Ln2Cu3(IDA)6]3 nH2O belong to the trigonal system with space group P3c1.,10.1021/ja200978u
335,{[Cu(4-bcba-H)] H2O}n<|>1*H2O<|>1,DOKDEN,thermal stability,300 to 510,K,Checked by thermogravimetric analysis,"The thermal stability of 1 was checked by thermogravimetric analysis (Fig. 2), which revealed a temperature range (300 to 510 K) of stability with no observable weight loss.",10.1039/b806616g
336,{[Cu(4-bcba-H)] H2O}n<|>1*H2O<|>1,DOKDEN,surface area,1715,m2 g1,Calculated from the N2 adsorption isotherm,The BET (Brunauer–Emmett–Teller) surface area of 1 calculated from the N2 adsorption isotherm is 1715 m2 g1.,10.1039/b806616g
337,{[Cu(4-bcba-H)] H2O}n<|>1*H2O<|>1,DOKDEN,pore diameter,15,A˚,N/A,"The pore size distribution of 1, which was calculated by DFT methods in Fig. 5b, showed a pore diameter of only 15 A˚ dominating the distribution, which is consistent with the crystallographic results of large hexagonal 1D channels.",10.1039/b806616g
